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 Deterioration in voice quality following radiation therapy for the treatment of 
laryngeal cancers (LC) is well documented in literature. The majority of studies show that 
these voice problems are long term and in some cases permanent. Deterioration in voice 
quality, especially over a period of time could lead to significant communication 
difficulties in daily life or in some cases could even result in loss of profession. Despite 
the negative effects of radiation therapy on voice quality being well documented, few 
studies have focused on the efficacy of voice therapy in the irradiated LC population.      
 The purpose of this study was to investigate the efficacy of a well researched, 
evidence based voice therapy approach, known as Vocal Function Exercises (VFEs) in 
improving vocal function in patients who have been irradiated for LCs. The present study 
conducted in three systematic stages with distinct and related study aims. The first 
involved characterizing the head and neck cancer treatment seeking population at the 
University of Kentucky (UK). Stage 2 involved characterizing vocal function following 
irradiation for LC using a multidimensional assessment approach. Stage 3 was a phase 2 
clinical trial aimed at treating these deficits in vocal function identified through stage 2 
using a systematic evidence based voice therapy approach, Vocal Function Exercises. For 
the phase 2 clinical trial, the comparison group received vocal hygiene (VH) counseling. 
 Observations from stage 1 showed that majority of patients from the treatment 
seeking population at UK between a 3 year time period from 2008 to 2010 were 
diagnosed with laryngeal cancers and were treated with chemoradiation therapy. Stage 2 
demonstrated a multidimensional deterioration in vocal function following radiation 
therapy for laryngeal cancers. Stage 3 demonstrated a significant improvement in vocal 
function across the primary outcome measure (Voice Handicap Index) as a result of 
VFE+VH. Improvements were also seen in select parameters across the five domains of 
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(VFE) IN IMPROVING VOCAL FUNCTION IN ADULTS IRRADIATED 
FOR LARYNGEAL CANCERS: A THREE PART DISSERTATION 
 
ABSTRACT OF DISSERTATION 
voice assessment in the VFE group. No significant improvements were observed in the vocal 
hygiene group in any parameters in each domain of voice assessment. 
 Our study demonstrated adults irradiated for laryngeal cancers demonstrated a multi-
dimensional deterioration of vocal function. These changes were long term since study 
participants were 2- 7 years post radiation therapy. Implementation of VFE+VH demonstrated a 
significant improvement in voice related quality of life and select parameters across the five 
domains of voice assessment. The present study demonstrated promising preliminary evidence 
for the use of VFE+VH to improve vocal function in patients irradiated for laryngeal cancers.  
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CHAPTER 1: INTRODUCTION 
   The curative role of radiation therapy (XRT) in the treatment of laryngeal cancers is 
well documented. Early laryngeal cancers can be treated with XRT alone, while advanced 
laryngeal cancers are often treated with a combination of chemotherapy and radiation therapy.1-3 
Radiation therapy, however, was not always the primary mode of choice for treatment of 
laryngeal cancers. A shift in the treatment trends of laryngeal cancers occurred in the early 1990s 
following completion of a clinical trial conducted by the Department of Veteran’s Affairs (VA) 
Laryngeal Cancer Study Group. The clinical trial completed by the VA showed comparable 
survival rates between primary chemoradiation therapy and total laryngectomy for the treatment 
of laryngeal cancers.4  Prior to 1990, advanced laryngeal cancers were primarily treated with 
surgical resection which involved complete removal of the larynx, also known as total 
laryngectomy. If the extent of the cancer warranted further intervention, patients were treated 
with radiation therapy after surgery. A total laryngectomy is associated with significant morbidity 
since it results in the alteration of a patient’s anatomy such that breathing subsequently takes 
place through a permanent tracheostoma. Undergoing total laryngectomy also means losing one’s 
natural source of voicing, the larynx itself. Consequently, following results from the VA study 
and a 10-year follow-up study which supported the initial findings,5 an increasing number of 
patients with laryngeal cancers have been treated primarily with radiation therapy, with or 
without chemotherapy, with the intent of preserving laryngeal structure and function.  
 Preservation of structure through radiation therapy, with or without chemotherapy for 
treatment of laryngeal cancers has not necessarily led to preservation of function. A number of 
studies have documented long-term voice and swallowing problems post-radiation, consequent to 
radiation-related toxicity. These prolonged, and in some cases permanent, post-radiation voice 
and swallowing problems are indicators that preserving laryngeal structure does not translate to 
preserving laryngeal function. In fact, collateral damage to the laryngeal, oral, and oropharyngeal 
structures caused by radiation toxicity absent chemotherapy is a well-documented clinical entity.6-
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9  Radiation damage to the larynx results in edematous and dehydrated tissues, leading to 
excessive compensatory compression of laryngeal structures during phonation, thus affecting 
vocal fold vibratory characteristics and impacting perceptual vocal quality.8,10-12  
 Another characteristic feature of radiation toxicity is delayed injury. Consequently, in 
addition to acute changes to the laryngeal mechanism, ongoing damage occurs as a result of 
radiation toxicity. Acute and long-term deterioration of voice quality post-radiation may lead to 
significant communication deficits in daily life or in some cases may result in loss of livelihood. 
Therefore, post-radiation therapy voice rehabilitation is important. Unfortunately, there is a dearth 
of knowledge with respect to voice rehabilitation in the irradiated population. Only four studies 
have investigated the efficacy of voice therapy in post-radiation laryngeal cancer patients, with no 
recommended standardized treatment.13-16 In these existing studies, vocal hygiene (VH) 
counseling is an approach that is commonly recommended.13-17 However, results of outcomes 
research related to VH demonstrate that this therapy approach may be more effective when 
coupled with a more exercise-intensive physiologic voice therapy approach.18-20 The Vocal 
Function Exercise (VFE) program is one such evidence-based physiologic approach to voice 
therapy.19,21 
 VFEs include a series of isometric and endurance-based exercises aimed at strengthening 
laryngeal musculature, improving vocal fold vibratory characteristics, and balancing the three 
sub-systems of voice production, respiration, phonation and resonance.22 Although VFEs have 
been employed successfully in treating a variety of voice disorders, the efficacy of this approach 
for improving vocal function in patients who have undergone XRT for laryngeal cancer has not 
been established.18,19,22,23 The overall objective of this study was to investigate the efficacy of 
VFEs to improve vocal function in adults irradiated for laryngeal cancers. This investigation was 
performed in three systematic stages, which are described briefly in the next section. 
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Dissertation Stages 
Stage I primary objective  
This stage involved characterizing the trends in head and neck cancers among a treatment-seeking 
population at the University of Kentucky Otolaryngology clinic.  
Stage I rationale: Rehabilitation following laryngeal cancers is especially relevant to the study 
population in the present dissertation since all participants of the study were residents of 
Kentucky. Laryngeal cancers are a subgroup of head and neck cancers. At 13.5%,24,25 Kentucky 
has the highest incidence rate for head and neck cancers in the United States (U.S.).25,26 The 
association between smoking and head and neck cancer risk is strongest for the laryngeal cancer 
subgroup.27 Furthermore, while the overall incidence of head and neck cancers (HNC) continues 
to decrease throughout the U.S., Kentucky has alarmingly shown a rise of 1.6% in the incidence 
of HNCs since 2007.24 The high incidence of HNCs in Kentucky can be linked to the increased 
prevalence of tobacco use in the state, since 90% of HNCs occur after prolonged exposure to 
tobacco and/or ethanol.27,28 Unfortunately, within the U.S., Kentucky leads in smoking prevalence 
rates.29 Within Kentucky, smoking rates are higher for Appalachian Kentucky (rural Eastern 
Kentucky) as compared to the urban regions within Kentucky.29 Within the subgroups of all 
HNCs, laryngeal cancers show the highest incidence rates (5.7 per 100,000) in Kentucky.24 As a 
result, large numbers of individuals within the state receive treatment for laryngeal cancers. This 
initial stage of research helped in identifying my target population, specifically patients who have 
been treated with radiation therapy for laryngeal cancers. Individuals identified through stage I 
were subsequently recruited for stage II. The following section briefly describes the primary 
objective and rationale for stage II. 
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Stage II primary objective                                                                                                           
The primary objective of stage II was to establish the effects of radiation therapy on vocal 
function in adults irradiated for laryngeal cancers, as assessed by the five domains of voice 
assessment.                                                                                                                                   
Stage II rationale: A number of studies have documented the undesirable effects of radiation on 
vocal function.1,9,30-32 However, these studies used limited outcome measures to assess voice 
production following radiation therapy. Normal vocal function or voice production is dependent 
on an interaction of physiological and psychosocial factors. Consequently, vocal function is best 
assessed with measures that account for both physiological as well as psychosocial measures 
using a multidimensional voice assessment battery, which utilizes the five domains of voice 
assessment.33 These measures include stroboscopic (laryngeal visualization), acoustic, 
aerodynamic, patient self-report and auditory-perceptual parameters.33 To this end, assessment of 
vocal function in my study population was assessed using this multidimensional assessment 
battery in patients following XRT for laryngeal cancers. Vocal function of irradiated individuals 
was also compared to a control group of individuals who were matched in terms of age, sex and 
smoking habits. This stage was meant to identify the nature of voice problems faced by patients 
irradiated for laryngeal cancers and also establish a patient’s perspective on the impact of these 
voice problems on the individual. Results from stage II highlighted the deleterious effects of 
radiation therapy on vocal function, thus creating a lens through which to investigate optimal 
rehabilitation techniques. 
Stage III primary objective                                                                                                                     
The primary objective of stage III was to investigate the efficacy of Vocal Function Exercises 
(VFE) in improving voice production in adults radiated for laryngeal cancers, as compared to 
vocal hygiene therapy. This stage was designed as a pilot study to collect preliminary data on the 
efficacy of VFEs in the irradiated population to support a possible future multi-center trial. 
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Rationale for Stage III: Despite post-radiation voice problems being well-documented in 
literature, only four studies have investigated the efficacy of voice therapy in the laryngeal cancer 
population.13-17 The voice therapy interventions across all four studies, however, were varied and 
not specified. Central to treatment approaches across all studies was vocal hygiene counseling. 
The outcomes research on vocal hygiene as a sole method of treatment, however, is not 
favorable.19,20,34 In fact, previous studies have shown vocal hygiene works best when coupled 
with a more exercise-intensive physiologic voice therapy approach.19,20,34 The Vocal Function 
Exercise (VFE) program is one such prescriptive evidence based physiologic voice therapy 
approach and has been successful in treating various voice pathologies in schoolteachers, singers 
and the aging voice.18,23,35,36 Given the efficacy of VFEs in treating various voice disorders, this 
therapy approach was chosen as the experimental treatment modality for adults who experienced 
voice problems as a result of radiation therapy for the treatment of their laryngeal cancer.  
 This chapter was intended to provide the reader with an overview of the significance and 
rationale for the three stages of this dissertation. The next chapter provides a more detailed review 
of literature pertinent to the main study objective; investigating the efficacy of VFEs in improving 
voice quality in adults irradiated for laryngeal cancers.  
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CHAPTER 2: REVIEW OF LITERATURE 
This chapter reviews pertinent literature in the domains of radiation therapy for treatment 
of laryngeal cancers. First, laryngeal cancer trends in the United States are discussed. The second 
section will review literature pertinent to voice problems following radiation therapy. The third 
section will briefly discuss the available evidence on voice rehabilitation following radiation 
therapy for laryngeal cancers. The fourth section will discuss the rationale for choosing Vocal 
Function Exercises (VFE) as the treatment for voice problems following radiation therapy for 
laryngeal cancers.  
LARYNGEAL CANCER 
Laryngeal cancers are a sub-group of head and neck cancers that originate in one or more 
sub-sites of the larynx. The number of estimated new cases and deaths from laryngeal cancer in 
the United States in 2014 were 12,630 and 3,610 respectively.37 For the purposes of clinical 
staging, the larynx is divided into three sub-sites; glottis, supraglottis and subglottis.38 The glottis 
consists of the superior and inferior aspects of the true vocal folds, as well the anterior and 
posterior commissures.38 The supraglottis is comprised of the false vocal folds, arytenoids, 
aryepiglottic folds and epiglottis.38 The subglottis is comprised of the area from the lower 
boundary of the glottis to the lower margin of the cricoid cartilage.38 The most common 
histological type of laryngeal cancer is squamous cell carcinoma, which is associated with more 
than 90% of all laryngeal cancers.27,28  
Depending on the tumor stage and sub-site, laryngeal cancers can be treated with surgery 
alone, radiation therapy (XRT) alone, a combination of chemotherapy and radiation therapy or a 
combination of all of the above modalities. For the purpose of this dissertation, I focus on the role 
of XRT in the treatment of laryngeal cancers and its effects on laryngeal tissues and vocal 
function following completion of treatment.  
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Radiation therapy modalities used in the treatment of laryngeal cancers 
Radiation therapy for patients with laryngeal cancers is traditionally delivered via two 
modalities; wide field radiation therapy and narrow field radiation therapy. As the names suggest, 
wide field radiation therapy is delivered over a wide field of tissues, which in the case of a larynx 
cancer patient may include the primary site and neck.3 Narrow field radiation therapy, also known 
as intensity modulated radiation therapy (IMRT) delivers the required radiation dose in a 
concentrated area.1,39 Wide field radiation therapy is commonly used in the treatment of advanced 
laryngeal cancers since these tumors are often large and include cervical lymph nodes.39 IMRT is 
commonly used to treat early glottic cancers as it is successful in concentrating the radiation 
beam on smaller areas.39 Wide field radiation therapy causes greater collateral damage of 
surrounding tissues as compared to narrow field radiation therapy.39,40 Radiation dosage typically 
ranges from 60-70 Gy and is administered for 5-7 weeks.41,42  
Effects of radiation therapy on voice quality 
Since the 1990s, an increasing number of patients are being treated with XRT with the 
intent of preservation of laryngeal structure and function.3 However, with increasing outcomes 
research in the area of voice and swallowing rehabilitation, it is apparent that preservation of 
structure after radiation therapy does not necessarily translate into preservation of 
function.9,12,15,30,43-45 The following section describes the effects of radiation toxicity on vocal 
function.  
Voice problems following radiation therapy 
There are a number of studies that have documented the effects of radiation on voice 
quality. Since a majority of these studies were retrospective chart reviews, it was interesting to 
note that these studies frequently reported disordered voice status and findings years after 
radiation therapy was completed. These findings are a strong indicator of the prolonged 
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detrimental effects of XRT on vocal function. Normal vocal function is an interaction of 
physiological and psychosocial factors.46 Physiologically, normal voice production is dependent 
on a balanced interaction of respiration, phonation and resonance.21 The psychosocial aspect of 
voice production is dependent on the individual’s voice use in his or her environment with 
regards to activities of daily living and professional demands.47  Due to its multifactorial nature, 
voice production is best evaluated using a multidimensional voice assessment battery, which 
encompasses physiological and psychosocial factors of voice production. To this end, research on 
voice outcomes suggests that voice production or vocal function is best assessed through the five 
domains of voice assessment which includes visual perceptual parameters (laryngeal imaging), 
auditory-perceptual parameters (clinician’s perception of voice quality), patient perception 
(voice-related quality of life), acoustic analysis and aerodynamic analysis.33 Studies that have 
investigated voice outcomes following radiation therapy have used one or more, but not all 
recommended parameters from the five domains of voice assessment. The following section 
provides the reader with a brief description of procedures contained within the five domains of 
voice assessment. The section has a special focus on select parameters in each domain that were 
chosen as assessment parameters for stage 2 and stage 3 of the present dissertation.  
Domain 1: Auditory Perceptual Measures 
Ray Kent said “the ear is an essential tool of the speech-language pathologist”.48 
Auditory perceptual assessment of voice quality essentially involves a clinician rating a patient’s 
voice disorder or dysphonia using various descriptive parameters. These parameters can be 
general, for example, “patient presents with moderate dysphonia” or can be more specific to 
features heard in patient’s voice, for example, “patient presents with a moderate degree of 
roughness, and mild breathiness and strain”. An auditory-perceptual evaluation is one of the most 
traditional and widely used methods of voice assessment. However, as is evident from these 
variable descriptions above, speech-language pathologists (SLPs) are recommended to use 
9 
 
standardized assessments for auditory perceptual evaluation of voice to ensure consistency 
amongst clinicians and in turn strengthening external validity. There are various scales that are 
utilized in the auditory perceptual evaluation of voice but few that have been standardized. Two 
of the most widely used scales for voice assessment are the GRBAS 49 and Consensus Auditory-
Perceptual Evaluation of Voice (CAPE-V).50 The GRBAS scale is easy to administer and was 
developed to rate vocal quality within five perceptual categories: overall grade (G), roughness 
(R), breathiness (B), asthenia (A), and strain (S). However, its sensitivity in detecting vocal 
alterations has been demonstrated to be lower than that observed with CAPE-V, possibly because 
GRBAS is an ordinal scale with only three alternatives (mild, moderate, and severe). The 
GRBAS has also been shown to be less sensitive than CAPE-V to evaluate subtle differences in 
voice quality.51 The use of the CAPE-V has been highly recommended and SLPs are being 
increasingly being encouraged to use the CAPE-V. Since its inception, the CAPE-V was devised 
to promote the standardization of evaluating and documenting auditory-perceptual judgements of 
voice quality. 52,53 The CAPE-V assesses perceptual vocal parameters which are (a) Overall 
Severity; (b) Roughness; (c) Breathiness; (d) Strain; (e) Pitch; and (f) Loudness. The CAPE-V 
displays each parameter accompanied by a 100- millimeter line forming a visual analog scale 
(VAS). Please see Appendix 1 for CAPE-V form. Judgments are marked on each scale on the 
CAPE-V: “MI” refers to "mildly deviant," “MO” refers to “moderately deviant,” and “SE” refers 
to "severely deviant."   Its greater sensitivity in detecting small differences in the voice, as 
compared with GRBAS, has been attributed to the use of its visual analog scale. 50,54,55 A slightly 
improved rater reliability using the CAPE-V to make perceptual judgments of voice quality, in 
comparison with the GRBAS scale, has also been reported.51 The present dissertation study 
utilized CAPE-V scores as the outcome measure for the auditory-perceptual domain given its 
standardization, high reliability and its high recommendation to being the auditory perceptual 
scale of choice. The following section gives us a brief description of the reliability and validity 
measures for the CAPE-V. 
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CAPE-V: The CAPE-V has demonstrated criterion validity and both intra- and interrater 
reliability. Intrarater reliability using Pearson’s r ranged from .35 to .82 depending on the voice 
quality measured.54 Strain had the lowest reliability and breathiness had the highest reliability. 
Interrater reliability was measured with Shout-Fleiss intraclass correlation coefficients (ICC) and 
ranged from .28 to .76 with pitch having the lowest reliability and overall severity having the 
highest reliability. Zraick et al., reported the intra and interrater reliability of this instrument.53 
Pearson’s r for intrarater reliability revealed the following: Overall severity .57, Roughness .77, 
Breathiness .82, Strain .35, Loudness .78, Pitch .64. Interrater reliability using Shout-Fleiss 
intraclass correlation coefficients revealed: Overall severity .76, Roughness .62, Breathiness .60, 
Strain .56, Loudness .54, Pitch .28.53  
Domain 2: Patient self assessment 
Voice disorders can have a significant effect on quality of life.56 Patient self assessment 
scales for voice disorders evaluate the impact of a voice disorder on a person’s quality of life. 
There are several scales available for patient self assessment in the voice disordered population.56 
However, a previous review article rated the Voice Handicap Index (VHI) and the Voice-Related 
Quality of Life (V-RQOL) as the psychometrically strongest of the existing measures.57  The 
Voice Handicap Index (VHI), developed by Jacobson et al.,47 is a 30-item questionnaire designed 
to assess the patient’s perceived impact of a voice disorder in three domains: physical, emotional, 
and social. The Voice related Quality of Life (V-RQOL) 46 is a 10 item questionnaire which also 
probes patient perceived difficulty with their voice in physical and socio-emotional domains. 
Internal consistency of the V-RQOL has been demonstrated to be high at Cronbach’s alpha of 
0.89.46 VHI and VRQOL scores have been demonstrated to be highly correlated.58 For the 
purpose of this dissertation, the VHI was chosen as the outcome measure of choice since it has 
been used in other studies investigating the efficacy of voice therapy in the irradiated 
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population.15,16 Below is a brief description of reliability and validity measures directly related to 
VHI scores. 
Voice Handicap Index (VHI): Criterion validity was established by comparing the VHI scores 
with patient-perceived severity of their voice. Test re-test reliability for the three domains was 
Functional (r = 0.86), Physical (r = 0.86), Emotional (r = 0.92), and Total (r = 0.92). The 
minimum detectable change in the total score of 18 points was determined to indicate a clinically 
significant change in pre- and post-therapy measures.47 
Domain 3: Acoustic analysis 
An acoustic analysis of voice production offers the clinician an instrumental objective 
analysis of a patient’s voice. There are a number of acoustic measures available. However, for the 
purpose of this section we will review three common measures used across studies and which 
were used as outcome measures for stages 2 and 3 of the present dissertation study. It should be 
noted that frequency and intensity based-measures do have inherent limitations. However they 
continue to be used as outcome measures in studies because they can provide change scores 
demonstrating post-therapeutic voice changes.   
These limitations are related to their reliance on the accurate tracking of fundamental 
frequency during voice production. These limitations can be overcome by methods that rely on 
cepstral analysis of voice which is in turn is not dependent on fundamental frequency.59 As a 
result, commonly used perturbation and noise measures (jitter, shimmer, noise-to-harmonic ratio) 
are used in the analysis of sustained vowels,60  and cepstral measures are used in the analysis of 
connected speech and highly disordered voices.60  Below is a brief description reliability and 
validity of acoustic measures used in the present dissertation study. 
Perturbation measures: Jitter is the short-term cycle-to-cycle variation in frequency in a voice 
sample, whereas shimmer is the short-term cycle-to-cycle variation in amplitude. Both of these 
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measures failed to demonstrate strong reliability because of differences in extraction methods 
across systems and because highly dysphonic voice signals decrease reliability. 61 These measures 
are reliable for sustained vowels, but not for connected speech and highly dysphonic voices.60 To 
overcome this barrier, the present study also included the Cepstral Speech Index of Dysphonia 
which accounts for aperiodicity and connected speech.60  
Noise measures: Harmonics-to-Noise Ratio (HNR) is based on the premise that normal vocal 
production consists of a strong harmonic component with a smaller degree of aperiodic noise .62 
Voices which carry a stronger harmonic component compared to the noise component should 
yield better perceptual voice quality.  HNR validity has been examined by comparing HNR 
results to auditory-perceptual ratings of voice. Yumoto et al. 63 found a significant correlation (r = 
0.81) between HNR results and perceptual ratings. The reliability of HNR for repeated measures 
of subjects’ voices was examined by Bough et al.64 The study examined the intra- and inter-day 
reliability for measures of HNR. Intraclass Correlation Coefficients for HNR measures taken 
within a single day ranged from 0.93 to 0.98. Coefficients for measures taken across a series of 
days ranged from 0.761 to 0.86. 64 The present study used the Noise to Harmonics ratio which is 
an inverse ratio of the HNR and has been found to be highly reliable as well.65,66 
Cepstral Speech Index of Dysphonia (CSID): The cepstrum has been described by Noll 67 as a 
Fourier transform of the logarithm power spectrum. 65  The principal advantage of spectral 
analysis methods is that estimates of aperiodicity and/or additive noise may be achieved without 
the identification of cycle boundaries.60 A study by Awan, et.al. demonstrated that acoustic 
estimates of dysphonia severity can be achieved in both continuous speech and vowel contexts 
using a model incorporating spectral/cepstral measures. The study also demonstrated a strong 
relationship between perceptual (CAPE-V measures) and acoustic estimates of dysphonia using 
cepstral analysis (R=0.96, R=0.81).60  
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Domain 4: Aerodynamic Measures 
Aerodynamic measurement of voice production concerns measurements of air pressures 
and air flows that are meaningful in clinical diagnosis and treatment.  These measures may help 
interpret the valving activity of the larynx. The vocal tract is an aerodynamic sound generator and 
resonator system. Variations in the flow of air through it reflect changes in the “manner” of 
consonant & vowel articulations. Evaluation of airflow can provide insight into speech or voice 
system dysfunction and efficiency.65 The aerodynamic measures used for stages 2 and 3 of the 
present dissertation are described below with their reliability and validity measures.             
Subglottic pressure (PSub): Psub is a measure of air pressure beneath the vocal folds necessary 
to overcome the resistance of the approximated folds to initiate and maintain phonation.65 
Estimated subglottic pressure is taken from a pressure sensing tube placed in the mouth during 
production of a pressure consonant, typically /p/. Because the pressure in the lungs rapidly is 
transmitted to the lips a useful estimate of the subglottic pressure can be obtained. 65 Subglottic 
pressure has established criterion validity when compared to tracheal puncture. Direct measures 
of subglottic pressure and indirect estimated subglottic pressure at the lips have been 
demonstrated to have comparable results.65                                                                                
Mean airflow rate: The mean airflow rate of a speech sample refers to the average rate of 
airflow during a given production.65 The mean airflow rate of a speech sample refers to the 
average rate of airflow during a given production.65 This measure is commonly taken using an 
anesthesia-type mask placed over the nose and mouth so that oral airflow during vowel 
production is passed through a pneumotachometer which senses pressure changes and 
mathematically converts these into airflow rates.                                                                
Laryngeal Airway Resistance: To calculate mean estimated subglottic pressure and mean 
airflow rate, syllable trains of a pressure consonant and a vowel may be used, usually /pa/. 
Pressure is sensed during the consonant and airflow is transduced during the vowel. These 
measures may be interpreted individually or as a ratio of pressure to flow, termed laryngeal 
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airway resistance. Smitheran and Hixon 68 calculated the reliability with intraclass correlation 
cofficients of laryngeal airway resistance across three sessions using normal participants to be 
0.96.  
Domain 5: Laryngeal imaging or Visual Perceptual Measures 
Laryngeal stroboscopy is a commonly used clinical method to assess vocal fold vibration. 
Another visualization method that is gaining popularity is high speed laryngeal imaging since it 
helps overcome the instrumental limitations of laryngeal stroboscopy.69 Although high speed 
laryngeal imaging is gaining popularity as a method of assessing vocal fold vibration, it is not 
readily available in a number of clinical settings. As a result, its clinical utility continues to be 
under investigation. Stroboscopy and high speed laryngeal imaging permit direct visualization of 
the vibrating vocal folds, allowing detailed assessment of laryngeal structure and function.70 
Because of the large number of vocal fold vibration parameters and somewhat subjective nature 
of interpreting visual examinations, these measures do hold reliability concerns. Some of these 
concerns include examiner bias, clinician training, and lack of standardization in rating 
parameters. Quantification of imaging parameters has not gained universal acceptance clinically 
because of its cumbersome nature.71,72 There are, however, many rating scales that may be used to 
guide interpretation of imaging parameters.70,73-75 There is some reliability data in interpretation 
of imaging parameters which supports its use. Intrajudge reliability for overall ratings has been 
demonstrated to range from 0.31 to 0.97,73 and interjudge reliability ranged from 0.75 to 0.98.76 
 Since the previous section has informed the reader on select parameters and their role in 
the assessment of voice disorders, the next section provides the reader with a brief description of 
study findings across the five domains of post-radiation voice assessment for patients treated for 
laryngeal cancers. 
Stroboscopic findings: In a detailed study performed by Lehman et al (1988),77 significant 
abnormalities were seen on stroboscopic analysis in patients irradiated for stage I glottic cancers. 
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Around 60% of patients showed irregular vocal fold closure, 65% showed increased supraglottic 
activity, 85% showed irregular vibratory margins, 80% showed shorter phase closure, and 85% 
showed irregular phase symmetry. The stroboscopic finding which was consistent across the 
group was decreased vibratory amplitude not only on the treated vocal fold but also on the non-
diseased fold. These findings were consistent with those in a study by McGuirt et al. (1994)12 and 
Wedman et.al78 that reported decreased mucosal wave on both the affected and non-diseased fold. 
In addition, subjects showed signs of muscle tension dysphonia, ventricular phonation, and partial 
antero-posterior compression. 
Aerodynamic measures: McGuirt et al. (1994)12 revealed mean laryngeal airway resistance 
(LAR) values 4.5 times greater than normal values (mean=177cmH2O/L/s) in patients who had 
been irradiated for T1a glottic cancer. These LAR values were comparable to those in a study by 
Dworkin (1997)30 who found that none of 12 irradiated patients attained normal aerodynamic 
measures. Increased airflow rates in patients who had undergone radiotherapy (n=6) were also 
observed in a study by Tamura (2003)79 in which mean airflow rates of 165 cc/s were measured. 
Increased aerodynamic resistance values reflect the signs of supraglottic hyperfunction seen 
stroboscopically and are also indicative of issues with glottal valving during phonation. 
Acoustic measures: A majority of studies showed that radiation therapy had a negative impact on 
voice production demonstrated by increased perturbation and noise measures. Voice production 
was gradually found to improve over 3-6 months post radiotherapy. However, none of the post-
treatment values were within the normal range. 78-80                                                                                                    
Auditory-Perceptual findings: Auditory-perceptual findings from previous studies report varied 
vocal symptoms. Perceptually patients often present with hoarseness, decreased volume, 
increased strain and persistent voice changes.8,13,81  
Voice-related quality of life: A recent study by Karlsson, et al. (2016) 17 that investigated voice-
related quality of life in patients with early and advanced laryngeal cancers revealed no significant 
differences between pre-radiation and post-radiation scores one year after completion of treatment. 
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These results indicate that the deterioration in voice quality perceived by the patient as a result of 
laryngeal cancer did not improve after completion of treatment to eliminate laryngeal cancer.17 A 
study that investigated voice problems as a result of radiation for early glottic cancers 
demonstrated that 87.8% of the patients sampled reported their voice as being abnormal, ranging 
from slight to moderate dysfunction.82  From the above clinical findings, it is established that 
patients irradiated for laryngeal cancers experience long-term voice problems that affect quality of 
life. The next section provides a brief description of voice intervention studies in the irradiated 
laryngeal cancer population.  
Voice rehabilitation following radiation therapy for laryngeal cancers 
  Only four studies document the application of voice therapy for individuals irradiated for 
laryngeal cancers.13-16 Two studies by Van Gogh et. al15,16 focused on voice rehabilitation in 
patients following irradiation for early glottic cancers, and studies by Tuomi et.al14 and Bergstorm 
et. al13 included patients who had received XRT for early and advanced laryngeal cancers across 
all laryngeal sub-sites.  
Van Gogh et.al, reported improvements in Voice Handicap Index (VHI) scores for 
patients irradiated for early glottic cancers following voice therapy interventions.16  The second 
study by Van Gogh et.al15 followed patients who had received voice therapy following irradiation 
for early glottic cancer for one year post-treatment to investigate if the effects of voice therapy 
were maintained. Their study demonstrated that beneficial short-term effect on the mean VHI, 
percent jitter, and shimmer were maintained after more than one year of follow-up. Voice 
rehabilitation in both studies included vocal hygiene with non-specified voice and breathing 
exercises. The control group in both studies did not receive any voice treatment. 
Results from the study by Tuomi et.al14 showed that patients who received vocal 
rehabilitation experienced improved self-rated vocal function after rehabilitation. Patients with 
supraglottic tumors who received voice rehabilitation had statistically significant improvements in 
voice quality and self-rated vocal function, whereas the control group did not. In a randomized 
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controlled trial, Bergstorm et.al,13 reported that subjects receiving voice rehabilitation showed no 
functional decline in vocal roughness 6-12 months post radiation therapy and perceived their 
voices to improve to a greater extent as a result of voice rehabilitation than the control group. In 
both studies, the control group received voice education and vocal hygiene as an intervention. The 
study by Bergstorm et.al described their voice rehabilitation intervention as a “structured hierarchy 
consisting of both direct and indirect voice interventions, including tasks such as breathing, 
relaxation, posture and specific physiology-targeted phonation exercises.”13 Tuomi et.al14 listed 
their voice therapy activities hierarchically; however specific production tasks under each activity 
were not specified.  
From the four study results reported above, it appears as though voice therapy or voice 
rehabilitation was beneficial in patients irradiated for both early as well as advanced laryngeal 
cancers. However, none of the studies specified a systematic or consistent voice therapy approach 
across all patients.  
The present dissertation study was aimed at using an evidence- based prescriptive voice 
therapy approach in individuals irradiated for laryngeal cancers. The next section focuses on the 
rationale behind choosing Vocal Function Exercises as the experimental intervention method.   
 
Rationale for choosing Vocal Function Exercises as choice of experimental intervention 
There are a number of voice therapy methods or voice therapy orientations that have been 
used over the years for the treatment of voice disorders.34,83 Based on a review article by Thomas 
and Stemple,20 three primary orientations to the treatment of functional voice disorders have 
emerged in literature; hygienic voice therapy, symptomatic voice therapy and physiologic voice 
therapy. The following section provides the reader with a brief description of each of these voice 
therapy orientations.  
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Hygienic voice therapy: Hygienic voice therapy is based on the belief that many functional voice 
disorders are caused and maintained by behaviors that can damage laryngeal structure and 
function, and subsequently, eliminating these behaviors will result in improved vocal 
performance.20 Often, hygienic voice therapy is a precursor in managing voice disorders and is 
most effective when used in combination with other techniques.19,20,84,85 When compared to no 
treatment at all, vocal hygiene has been proven to be effective in the management of voice 
disorders;85,86 however in studies that compared vocal hygiene to other voice therapy 
interventions such as Vocal Function Exercises and Resonant Voice Therapy,19,87-89 the consistent 
finding across all of these studies was an improvement in voice quality when a more physiologic 
approach was employed. Some authors describe vocal hygiene as an indirect method of voice 
rehabilitation since it targets behaviors around voice use and not vocal physiology directly.86,88 It 
is clear from these studies that while vocal hygiene is an important part of voice therapy, it is not 
effective as a stand-alone mode of treatment and often more effective when coupled with a more 
direct therapy approach.20 More specifically, when vocal hygiene education was compared to 
voice therapy exercises in subjects irradiated for early glottic cancers, it was the voice therapy 
exercise group that showed long term significant improvement in voice quality.15,16 
Symptomatic voice therapy: Organized by Daniel Boone (1971), symptomatic voice therapy 
operates on the basis that voice disorders are caused by functional misuse or abuse of vocal 
components including respiration, pitch and loudness. Symptomatic voice therapy aims at 
modifying these deviant vocal symptoms that are expressed as breathiness, low pitch, glottal fry 
phonation, use of hard glottal attacks or using an inappropriate pitch in general.90,91 Various 
facilitation techniques employed in symptomatic voice therapy are geared towards reducing or 
eliminating these inappropriate components and promoting better voice production. Some studies 
have described symptomatic voice therapy as a direct therapy method when compared to vocal 
hygiene.92,93 
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Physiologic voice therapy: 20,91 As the name suggests, this approach includes techniques that 
directly involve altering and modifying the physiology of the voice-producing mechanisms. 
Normal voice production is dependent upon a balance among the respiratory, phonatory and 
resonance systems. This requires a relative balance among the airflow from the lungs, strength 
and coordination of the intrinsic laryngeal muscles, and the structural and functional integrity of 
the vocal tract and participating resonating cavities. In addition, the emphasis of physiologic 
voice therapy is on maintaining the health of the vocal fold cover.91  
Some of the most commonly used physiologic voice therapy approaches are implementation 
of Vocal Function Exercises, Resonant Voice therapy and the Accent method of voice therapy. 
The rationale behind these methods is described below in detail: 
I) Vocal Function Exercises:21 Vocal Function Exercises, first described by Barnes and 
then further developed by Stemple20 are aimed at strengthening and rebalancing the 
three sub-systems of voice production, namely respiration, phonation and resonance. 
It is based on the principles of basic exercise physiology that state the role of 
resistance and endurance exercises in improving muscle function and strength.94,95 
The exercise program itself is comprised of a series of four exercises which include a 
warm up exercise, stretching, contraction and increased resistance exercises. The 
typical exercise program lasts for about 6-8 weeks depending upon patient progress. 
The exercise program like any other program of the same nature involves repetitive 
strengthening tasks, endurance tasks and relies heavily on patient compliance. Patient 
progress and technique therefore need to be tracked carefully through the exercise 
program. A number of studies have employed Vocal Function Exercises successfully 
in the management of voice disorders, both organic and non-organic.19,20,22,23 A 
number of outcomes studies have been reported that used VFEs across different high-
risk populations such as singers and school teachers.  
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II) Resonant Voice Therapy (RVT): RVT was first described in literature by Arthur 
Lessac and was developed further by Katherine Verdolini. Resonant voice is defined 
as voice production involving oral vibratory sensations, usually on the anterior 
alveolar ridge or higher in the face in the context of easy phonation.21 RVT is aimed 
at maximizing voice production by achieving a strong and clean voice quality in the 
presence of minimal vocal effort. This therapy method operates on the rationale that 
minimizing vocal fold impact during voice production would minimize the likelihood 
of vocal fold injury. Like VFEs, RVT too has been the subject of outcomes studies, 
either as a stand-alone method, or in conjunction with other voice therapy methods. 
19,89,96,97 
III) Accent Method (AM) of voice therapy: The AM targets holistically the improvement 
of the respiratory, phonatory, articulatory, and gesticulatory aspects of verbal 
communication in an integrated manner. The AM may be considered holistic also 
from the vocal point of view as it collectively and simultaneously targets the various 
parameters of voice such as pitch, loudness and timbre. The AM rests technically on 
three major principles: (1) optimal abdomino-diaphragmatic breath support; (2) 
rhythmic play of accentuated relaxed vowels with progressive carryover to connected 
speech, and (3) dynamic rhythmic body and arm movements. The therapeutic 
procedure consists of: (1) respiratory exercises; (2) phonatory exercises, and (3) 
articulatory exercises, by which the beneficial new vocal habits are transferred to 
connected speech. In the past, the accent method has been used successfully in 
treating both organic and non-organic voice disorders.98-100  
Of all of the voice therapy methods described above, the most researched voice therapy 
intervention has been Vocal Function Exercises. To date, there are 23 peer-reviewed studies that 
have demonstrated that VFEs are efficacious in enhancing vocal function in individuals with 
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disordered voices, individuals over the age of 60 years diagnosed with presbylaryngeus and 
professional voice users.18,19,22,35,36,69,87,88,91,101-114 In individuals with normal voices and elite voice 
users such as singers, VFEs were effective in enhancing vocal function. Based on the disturbances 
noted in voice production as a result of radiation-induced disruption in vocal fold vibratory 
parameters, VFEs may prove efficacious in improving vocal function post-XRT. 
In addition to a strong clinical evidence base, there are other factors that justify the use of 
VFEs following XRT for laryngeal cancers. These factors have to do with the unique muscle 
properties of intrinsic laryngeal muscles and the benefits of an exercise intensive program for 
improving voice quality following radiation damage to the larynx. In the next few sections, the 
reader will be informed on unique properties of laryngeal muscles, the effect of exercise on 
skeletal muscles, motor control theory and the effect of radiation therapy on intrinsic laryngeal 
muscles.  These findings contribute to a strong case for using a physiologic approach to voice 
therapy following XRT, which focuses on strength and balance training of the laryngeal 
musculature, specifically through Vocal Function Exercises (VFEs). 
Intrinsic Laryngeal Muscles (ILM), what sets them apart? 
Since ILMs are skeletal muscles, they have been thought to resemble limb skeletal 
muscles in terms of structure and function. However, unlike limb skeletal muscles, ILMs are 
constantly active during respiration and are protective in function as they serve to protect the 
airway. As a result it is important that these muscles remain more fatigue-resistant as compared to 
limb skeletal muscles.115-117 Therefore with the unique demand placed on these muscles, it has 
become apparent that they differ from limb skeletal muscles in certain key aspects. These 
differences are discussed further in the present section.  
Muscle fiber: Laryngeal muscle fibers are relatively smaller when compared to limb skeletal 
muscles118 but are comparable to extraocular muscle (25-50 µm).119  The mean fiber diameter for 
Thyroarytenoid (TA), Lateral cricoarytenoid (LCA), Posterior cricoarytenoid (PCA) and 
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Cricothyroid (CT) is around 20-35 µm118 which is smaller compared to limb muscles, which 
range from 35-75 µm.120                                                                                                                 
Contractile properties: The speed of contraction and sustainability of contraction of muscles are 
determined primarily by the muscle’s myosin heavy chain (MyHC-I) isoform. In human skeletal 
muscles MyHC-I yield slow contractions while IIa, IIx produce rapid contractions.121 In the rat 
model, laryngeal muscles show Type I, IIA and IIB myosins.117 Studies in rats and non-human 
primates suggest that the TA is nearly homogeneous in its myosin heavy chain expression, being 
composed entirely of fast, type II myosin. 122,123 Unlike reports in the rat and non-human primate 
model, human ILMs display a combination of fast and slow isoforms within a single muscle. 
Muscles responsible for glottic closure and airway protection demonstrate faster MyHC isoforms 
than abductors.115-117 Research on human laryngeal muscles has suggested that some laryngeal 
fibers are capable of contractile speeds that far exceed those of limb muscles.124                         
Mitochondrial density: Mitochondrial volume density is the portion of cellular volume occupied 
by the mitochondria (mitochondrial volume percent)125 or the percentage of the volume fiber 
occupied by the mitochondria. TA, PCA and CT muscles show higher densities of mitochondria 
when compared with limb skeletal muscles. 122,126 The constant activation of the muscle during 
life sustaining functions such as respiration require these muscles to be far more fatigue-resistant 
as compared to the typical demand of limb skeletal muscles.  
Since we have now established that ILMs are different from limb skeletal muscles in 
terms of size, role, and composition, the next section will describe the changes seen in laryngeal 
tissues and musculature following radiation therapy. 
Effect of radiation therapy on vocal fold tissue 
The elements most at risk of radiation injury in the larynx are the epithelia- both 
squamous and columnar- and the blood vessels. Cartilages of the larynx also appear to be an 
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important site of delayed injury.127 The response of the larynx to radical doses of radiotherapy 
varies from mild erythema to severe inflammation with edema and induration caused by 
obliterative vasculitis and local ischemia.128 In a retrospective study of 348 patients receiving 
radiotherapy as the primary treatment for laryngeal carcinoma, Mintz et al reported that chondritis 
developed after curative-dose radiotherapy in 15% of their patients.9 There are very few studies 
that have studied the effects of vocal fold muscle after radiation specifically. A study done by 
Tedla et al.129 investigated the changes in muscle structure of irradiated intrinsic laryngeal 
musculature. Comparisons were made between two groups of samples; those obtained from 
patients who had the total laryngectomy as their primary treatment modality and those who had 
salvage laryngectomy. Salvage laryngectomy is the term used for a total laryngectomy following 
failure of primary radiation therapy. For the salvage laryngectomy group, the time post radiation 
ranged from 7-15 months. The histological differences between the vocalis muscle, vocal process 
of the arytenoid, cricoarytenoid joint and superior and recurrent laryngeal nerves were compared. 
They found significant differences in the muscle structure as a result of radiation injury 
characterized by decreased number of muscle fibers, widening of spaces between muscle fibers 
and reorganization of muscle fibrils. These changes are indicative of increased atrophic changes 
in the irradiated laryngeal muscle as compared to non-irradiated muscle. They also found a 
change in the thickness of the perineurium of the recurrent laryngeal nerve and superior laryngeal 
nerve. The thickness was lesser in the irradiated group as compared to the non-radiation group. 
This could possibly influence the motor and sensory characteristics of the laryngeal vestibule. 
Although this examination focuses on the role of the larynx in voice production, it is relevant to 
note that this mechanism of injury may be a reason why swallowing problems characterized by 
silent aspiration are prevalent in patients who have been irradiated. 43,130 
A study by Johns et.al 31 demonstrated that human irradiated vocal folds demonstrated 
increased collagen transcription, with increased deposition and disorganization of collagen in 
both the thyroarytenoid muscle and the superficial lamina propria. An increase in fibronectin 
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levels was noted in the superficial lamina propria. Laminin decreased in the thyroarytenoid 
muscle. All of these findings would explain the decrease in vocal fold pliability following 
completion of radiation therapy. Whole genome microarray analysis demonstrated increased 
transcription of markers for fibrosis, oxidative stress, inflammation, glycosaminoglycan 
production, and apoptosis. Post radiation changes therefore extend to the level of gene 
transcription which can hinder treatment approaches that only target post- radiation structural 
damage. Interestingly, the study also demonstrated an increase in collagen content as greater time 
had passed since the completion of radiation therapy. This finding further highlights the late 
effects of radiation toxicity.  
Motor control theory and neuroplastic influences 
 From the studies that investigated voice quality after radiation therapy, it is apparent that 
a number of changes in vocal quality are a result of faulty voice use. From the previous section it 
is also apparent that a number of sensory and motor alterations take place as a result of radiation 
therapy. Studies that performed laryngeal examinations after radiation therapy demonstrated that 
this group of patients often exhibit compensatory behaviors such as laryngeal hyperfunction 
which are not conducive to normal voice production.12,79 It is possible that as patients undergo 
changes during and after XRT, they tend to develop adaptive and compensatory strategies as a 
result of the various pathophysiological changes occurring during treatment. Theories of motor 
control may help us understand this phenomenon better regarding not just physical changes but 
also the various environmental changes that result from the experience of radiation therapy. The 
field of motor control is directed at studying the nature of movement, and how movement is 
controlled. Motor control is defined as the ability to regulate or direct mechanisms essential to 
movement.131 Though application of motor control theories have been studied in greater detail in 
the Physical Therapy and Occupational Therapy literature, researchers have more recently tried to 
explain speech motor control based on these theories as well.132 Though these theories have not 
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been applied to explain voice production, there are a number of overlapping concepts which 
could better explain the compensation and adaptability of the vocal fold mechanism. 
One such concept is the interaction between the feedback and feedforward system of 
physiological motor control.133 This interaction between the two mechanisms could shed light on 
the compensatory vocal behaviors developed as a result of radiation therapy.  Feedforward 
control involves all techniques for controlling a motor apparatus (the effector organs, for 
example, muscle) without reference to one or more controlled variables (possibly muscle length 
or joint angles) describing the current state of the motor system. In contrast, feedback control uses 
some knowledge of the controlled variables to determine the outgoing motor commands. For 
example, the controller could assess the difference between the sensed state of the motor 
apparatus and a reference value for that variable. The controller could then seek to adjust the 
difference using negative feedback.134 Considering the alterations to sensorimotor components 
described in the previous section, the possibility of a shift in the feedforward and feedback 
mechanism is inevitable. The shift that is possibly occurring in the feedforward and feedback 
mechanism as a result of laryngeal injury secondary to radiation is probably why individuals 
compensate through hyperfunction, which in turn produces a strained voice quality. This shift 
which results in faulty compensatory voice production strategies also makes a case for why voice 
therapy needs to be more task-specific and focus on changing movement based on striking a 
balance between respiration, phonation and resonance. Another issue that further adds complexity 
to ongoing structural changes is that sensory deprivation caused as a result of radiation damage to 
the larynx is late onset. Studies investigating neuroplasticity have demonstrated that neuroplastic 
changes are more striking early in life during the critical period of development.135 Therefore 
retraining a highly specialized mechanism like the larynx , which is now mechanically injured, 
genetically altered and which now suffers from late sensory deprivation, can prove challenging. 
As involved as the peripheral motor and sensory systems are, the role of the cortex cannot be 
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ignored. As is evident from studies, individuals continued to show compensatory and deviant 
voice production years after radiation was completed. With ongoing alterations in sensory and 
motor mechanisms consequently affecting the feedforward and feedback mechanisms, it is 
possible that cortical representations are being altered as well. Areas for laryngeal control in the 
cortex have been identified 136-138 and while the effects of radiation to the larynx on cortical 
mapping have not been studied, it can be expected that the various sensory and motor changes 
taking place would influence cortical reorganization as well. We shall describe the basis for our 
theory of cortical reorganization in the next section.  
Neuroplastic influences of voice problems on cortical representation: Cortical reorganization 
following deafferentation and amputation has been studied extensively in the animal model. 139-144 
Reorganization following amputation is similar in the pattern which it follows considering the 
taking over of the now deprived field by neighboring areas. The formation of ‘new’ 
representations is also indicative of the fact that there are certain latent anatomical regions that 
come into play when certain regions are completely deprived of sensory input, as seen in cases of 
nerve resection or amputation. Deafferentation studies in adult macaque monkeys showed that it 
was not just the receptive fields of the surrounding digits that took over the deprived area; but it 
was also neighboring areas that represented the facial receptive field area that expanded over the 
deafferented region.143 These findings were supported by further exploration of cortical 
reorganization in adult primates.141 Similarly as changes in the perineurium of the recurrent 
laryngeal nerve take place as a result of radiation therapy, it is possible that cortical 
representations become weaker as a lack of sensory and motor input. Is this why patients in some 
cases display severe dysphagia and voice issues over a long period of time after the completion of 
radiation? As mentioned before, this has not been studied, and it is possible that laryngeal cortical 
representations reorganize differently. But until investigated further, this can be considered as a 
strong factor in recovery. 
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In studies of cortical reorganization and recovery, one of the major influences in recovery 
was activity-dependent neuroplasticity. The role of repetitive practice and increasing task 
complexity has been linked to a better quality of neuroplastic change. Considering repetitive 
nature of tasks, the role of exercise in neuroplastic changes has been the subject of investigation. 
The next section focuses on the effects of exercise on neuromuscular changes and gene 
expression. 
Exercise and neuroplasticity in influencing gene expression: Plasticity is the interface between 
physical and neural activity.145 Studies have repeatedly shown that, depending on intensity, 
endurance exercise increases neurotrophins and thereby induces neuroplasticity.146-151 An increase 
of Brain Derived Nerve Factor (BDNF) has been interpreted as an important factor raising adult 
Central Nervous System (CNS) plasticity. In addition, aerobic exercise up-regulated expression 
of insulin-like growth factor-I (IGF-1) and raised uptake of peripheral circulating IGF-I into the 
brain.148,149,152 Studies have shown that IGF-I increases neurogenesis and also angiogenesis.146  
Basal and exercise-induced angiogenesis are regulated in part by vascular endothelial growth 
factor (VEGF). VEGF is produced by skeletal muscle cells during exercise and can be released 
into the circulation, which also seems to be necessary for the effects of aerobic exercise on 
neurogenesis.146 Considering findings on diminished vascular supply to tissues after radiation 
therapy, this is a possible indicator that exercising laryngeal muscles may improve vascular 
supply to the irradiated muscle. A study by Gomez-Pinnilla (2002)151 investigated the effect of 
voluntary exercise on neuroplasticity. Voluntary exercise increased the expression of several 
molecules associated with the action of BDNF on synaptic function and neurite outgrowth in the 
lumbar region of the spinal cord and the soleus muscle. While we acknowledge that the study 
focused on limb skeletal muscles, there were a number of interesting findings related to activity-
dependent plasticity. Their study demonstrated that voluntary physical activity can lead adult 
sensory neurons to enhanced axonal regeneration after subsequent axotomy. 151 This again has 
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been linked to the increase in neurotrophins following exercise. This study also emphasized the 
effect that voluntary exercise has on synaptic plasticity subsequently improving neuromuscular 
functions.151   
Exercises and peripheral neuroplasticity: Exercise has been shown to be beneficial in not only 
improving muscle strength in normal muscle, but also in aging and inflamed muscles.153 Using 
high-intensity, low-repetitive, strength-type exercise, human skeletal muscle tissue exhibits 
marked gains in strength that are due both to neuronal adaptations and to an increase in muscle 
cross-sectional area. 154 A study by Luthi et al studied the effects of resistance training on muscle 
structure in human subjects.154 They found an increase in muscle cross sectional area and muscle 
size. Structural and functional properties of skeletal muscle generally correlate to the level of 
demand placed on individual muscles.154 As demand increases, skeletal muscle can adapt via an 
increase in myofiber size and an alteration in the composition of the metabolic and contractile 
proteins expressed.95 Training programs that have employed relatively pure shortening, 
lengthening, or isometric loading have demonstrated that each of these three modes of loading 
can stimulate muscle adaptations, including hypertrophy and strength gains.94,154 It is well 
established that a prolonged program of resistance training brings about fiber type conversions 
within the trained muscle.94,154 These findings are also influenced by repetitive exercise patterns. 
Most changes were observed after the first 4 weeks of exercise. One of the methods of 
documenting if these changes are more permanent would be to document changes in gene 
expression as a result of exercise. These changes would be indicative of a more long-lasting 
change in muscle structure. Would resistance exercises during the radiation period slow down or 
nullify delayed injury? If yes, voice therapy could have important implications on not just voice 
but swallowing rehabilitation as well. A study by Booth and Neufer (2005)155-157 describes the 
mechanism of gene expression following exercise. If work demand on a muscle increases even 
for relatively short periods, the muscle adaptively remodels its protein composition to allow 
energy to be used more efficiently when the muscle contracts. For skeletal muscles to exhibit 
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plasticity, specific genes in the muscle sense the change in muscle usage and respond by altering 
the quantities of proteins they produce. Neufer155 measured gene changes by measuring mRNA 
concentration, or how quickly a specific gene was transcribed. He investigated whether exercise 
activated a specific target gene and whether this took place within a specific time period. Three 
categories of genes were expressed as a result of exercise, mainly endurance training, based on 
the duration of their activities. These included 1) stress response genes (mainly consisting of heat 
shock proteins) which were activated during the later phases of endurance training, 2) metabolic 
priority genes: proteins which are required as a consequence of particular metabolic stress, for 
example when blood glucose or blood oxygenation levels drop, and 3) mitochondrial enzyme: 
which is directly responsible for the energy production in a cell.  
Though these changes were documented in limb skeletal studies, the concept can be 
applied to endurance training with intrinsic laryngeal muscles.  Changes in muscle composition 
based on the effect of fictive exercise in normal rat intrinsic laryngeal muscle have been 
established.158 It would be of interest to see the changes in gene expression and muscle 
composition following radiation therapy. 
The effect of exercise on vocal fold muscles 
From the previous sections it is clear that while ILMs are skeletal muscles, they are 
highly specialized as compared to limb skeletal muscles. As is apparent from previous studies 
there is ample evidence to conclude that endurance and resistance exercises improve muscle 
strength in the limb skeletal muscle. However, in the previous section we also highlighted the 
differences between limb skeletal and intrinsic laryngeal muscles. It is apparent that intrinsic 
laryngeal muscles resemble extraocular muscles and are more fatigue-resistant than fast 
contracting skeletal muscle fibers. However, basic substrates that drive muscle strength such as 
mitochondrial content, oxidative metabolic capacity and quantity of neuromuscular junctions 
remain common between both limb skeletal and intrinsic laryngeal musculature. The effects of 
30 
 
chronic electrical stimulation on the rat TA muscle were investigated by McMullen et al (2011). 
158 The thyroarytenoid muscle was stimulated via nerve cuffs on the recurrent laryngeal nerve for 
a period of one week for one group and two weeks in the other group. Differences in muscle 
structure were compared at one-week intervals and two-week intervals. The authors found a 
decrease in mean thyroarytenoid fiber area, evidence of higher mitochondrial content in the 
muscle after chronic stimulation, and increase in the number of neuromuscular junctions in 
muscles that had been stimulated. These findings are similar to those changes seen in other 
skeletal muscles after endurance training. 159,160  The stimulated thyroarytenoid muscles displayed 
increased oxidative metabolic capacity which is a sign of adaptive progression in fast-twitch limb 
skeletal muscle undergoing endurance training. 161 The increase in neuromuscular junctions in 
stimulated group was also a significant finding.  Previous studies have reported an increase in 
neuromuscular junctions (NMJ) as a sign of activity dependent plasticity.162  Increased 
neuromuscular activity can influence NMJ structure, with NMJ remodeling being a common 
finding after endurance and resistance exercise. An increase in NMJ quantity or density would 
lead to an increase of the area in contact with the muscle fiber, which would result in more 
release sites and greater levels of transmitter release. 163 The only finding that did not match 
findings from other studies was a decrease in fiber size instead of an increase. The authors 
speculate the reduction in fiber size was possibly due to lack of load applied to the muscle. 164 
From the previous sections it is clear that exercise seems to be important in facilitating 
activity-dependent plasticity. More importantly, changes after exercise appear to be more long-
lasting since they influence gene expression.  
Summary 
 It is clear from outcomes studies after radiation therapy that XRT adversely affects voice 
production.12,30,81,165 There are a number of studies which have documented changes in vocal fold 
structure, objective voice data and also microscopic changes that influence laryngeal 
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tissues.12,30,81,165 The changes occurring at tissue level appear to be inflammatory, causing muscle 
weakness and stiffness.62,129 In addition, changes to the nerve and blood supply have also been 
documented.31,129 More concerning, ongoing changes are noted at the level of gene transcription 
even after completion of radiation therapy.31 The paucity of research on the treatment of these 
long-standing voice problems is concerning as well. The present review attempted to decide 
whether there is a rehabilitation method that would best treat voice disorders in this population. 
From reviewing rehabilitation research across other disciplines like physical and occupational 
therapy, exercise emerges as a common theme for neuromuscular rehabilitation. Though the 
effect of exercise has been studied in limb skeletal muscle more extensively, the basic mechanism 
of inflammation and exercise-based changes are similar to those seen in vocal folds after 
exposure to radiation. Considering the changes seen in the muscular and vascular damage in 
intrinsic laryngeal muscles as a part of radiation injury, exercising seems to be the choice of 
treatment to regain structural integrity. Studies state that exercise not only reduces inflammation 
but also promotes angiogenesis.146,150,152,161 These changes seem to occur in the presence of 
resistance and endurance training.146,150,152,161  When exercise was simulated in the rat intrinsic 
laryngeal muscles, changes seen were similar to those reported in limb skeletal muscles after 
endurance exercise, which is indicative of common strengthening patterns seen in ILMs after 
exercise.163 These changes were reflected in an increase in mitochondrial content as well as an 
increase in neuromuscular junctions.163 The increase in neuromuscular junctions is an indicator of 
activity-dependent plasticity as a result of exercise. Though these changes have never been 
studied in the larynx areas in the cortex, based on limb exercise research and amputation and 
deafferentation studies, cortical changes secondary to laryngeal muscle exercise is a feasible 
possibility. This could also be indicative of permanent changes occurring as a result of gene 
expression due to exercise. 156,157,163  
While evidence on exercise and neuroplastic changes is still speculative and needs to be 
investigated further, the need for more concrete, exercise-based voice rehabilitation is apparent 
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from voice therapy outcomes studies. The Vocal Function Exercise program is a prescriptive 
exercise program and is presently the most researched therapy program compared to other voice 
therapy interventions. However, we fully acknowledge that the choice of therapy methods across 
these studies is subjective, and we need more extensive and well-planned studies for voice 
therapy outcomes. The decision for a therapy plan for the irradiated laryngeal cancer population 
can only be made once the effects of various voice therapy methods are studied in greater detail. 
Until now, there have four studies that reported the positive effects of voice therapy in this 
population, but the intervention methods have not been specified.13-16 
The gap in research between disorder and treatment in this population is glaring. Based 
on the findings of this review, it appears as though a starting point for voice rehabilitation in this 
population is exercise that aims to strengthen the sub-systems of voice production. The VFE 
program is the only program presently that aims to strengthen and rebalance the laryngeal 
musculature through a series of resistance and endurance exercises.  The first step to voice 
rehabilitation would logically be to set a strong neuromuscular foundation and in addition retrain 
the irradiated laryngeal system by implementing VFEs to gain strength and balance of the 
laryngeal mechanism.  
The next chapter includes a detailed description of the first stage of the investigation 
targeted towards the completion of this dissertation study. This stage focused on characterizing 
the head and neck cancer population at a single center, the University of Kentucky Medical 
Center. Rehabilitation following laryngeal cancers is especially relevant to the population in 
Kentucky largely because of the high incidence rates of laryngeal cancers, and HNCs in general 
in the state. This study stage helped identify individuals who were irradiated for laryngeal cancers 
for later stages of the dissertation.  
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CHAPTER 3: STUDY I 
Study title: Addressing the head and neck cancer burden in Appalachian Kentucky: A single 
center experience 
Chapter 3 describes stage I of the dissertation study in detail. This stage of the study 
helped in identifying patients irradiated for laryngeal cancers at the University of Kentucky. 
However, in addition to laryngeal cancers, an increased incidence of head and neck cancers 
(HNC) has been reported in the state of Kentucky since 2007. In fact, at 13.5% Kentucky has the 
highest incidence of head and neck cancers in the United States. 24,37 As described in previous 
sections, laryngeal cancers are a sub-group of head and neck cancers (HNCs). Therefore, instead 
of limiting our investigation to laryngeal cancers only, we characterized the distribution trends of 
all HNCs seen at the University of Kentucky to highlight the HNC burden in Appalachian 
Kentucky. The present section includes the background, specific aims, methodology, results and 
discussion directly related to study 1. 
Background                            
Appalachian regions across the United States include 420 counties in 13 states 166 and are 
known to be regions associated with significant health disparities. 166,167  Health disparities 
between Appalachian and non- Appalachian counties have chiefly been attributed to the 
geographic isolation of most Appalachian counties, low socioeconomic status, low levels of 
education and literacy, and limited access to healthcare.166 These health disparities result in higher 
rates of heart disease, stroke,168 chronic conditions and cancer in Appalachian vs. non- 
Appalachian regions. 166,169,170 The growing incidence of cancer in Appalachia has been of great 
concern with cancer incidence and mortality rates being much higher as compared to non- 
Appalachian regions.170  Increased incidence and mortality of cancer holds true for the 
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Appalachian counties within the state of Kentucky as well,24 in fact, to an even much graver 
degree .167 
Studies have shown that the 54 Appalachian counties of Kentucky have socioeconomic 
status factors which are the poorest among all Appalachian regions of the United States .171 
Limited finances and limited access to medical facilities has resulted in the medical needs of this 
population remaining largely underserved .166,167,172,173 With limited access to healthcare, it is not 
surprising that Appalachian regions of Kentucky show a higher incidence of lung, colorectal, 
cervical and head and neck cancers as compared to non- Appalachian regions.169 Associations 
such as Appalachia Community Cancer Network (ACCN) and Appalachian Regional Health 
(ARH) are attempting to address this growing incidence of cancers in Appalachian Kentucky 
through education and early detection programs.174  The Appalachia Community Cancer Network 
(ACCN) comprises a multidisciplinary team of collaborators from academic institutions and 
communities in Kentucky, West Virginia, Ohio, Pennsylvania, New York, Maryland, and 
Virginia. The ACCN, located at the University of Kentucky's Markey Cancer Center, addresses 
cancer health disparities in the Appalachian areas within these seven states, which are home to 
some of the most medically underserved and economically disadvantaged people in the United 
States.174  
While the ACCN has made significant efforts in Eastern Kentucky to address the cancer 
burden related to colorectal, lung, breast and cervical cancers ;167,175,176 the head and neck cancers 
have not been addressed. The incidence rates for head and neck cancer statistics for Kentucky in 
general have not been favorable.177 According to recent data reported by the Kentucky Cancer 
Registry (2007-2011), at 13.5 percent, Kentucky has one of the highest reported incidence of 
head and neck cancers (HNC) in the United States. 24,177 This is a matter of great concern since 
Kentucky is one of the few states where incidence rates of HNC have increased in the past few 
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years. 25  The rising incidence in HNC can be attributed to a high prevalence of smoking in the 
state at 28%, which is also the highest smoking prevalence rate in the country. 29   
When detected early, HNC are highly treatable and have significantly better five-year 
survival rates and low rates of treatment related morbidity.178,179  Improved treatment morbidity is 
due to the single modality treatment that is required to combat early cancers.175  Treatment for 
advanced stages of HNC results in significant morbidity including severe detrimental effects on 
speech and swallowing. 39 Multiple interventions including surgery, radiation therapy, 
chemotherapy, other surgeries and subsequent rehabilitation as a result of these treatments 
contribute to severe detrimental effects on quality of life and consequently increases treatment 
costs.175 These costs are related to the required multimodality treatments and multiple 
professionals involved in direct patient care. For patients who are financially compromised in 
regions such as Appalachian Kentucky, treatment costs only add to the disease burden.  
When assessed in totality, the multiple referenced hurdles to medical care (high 
prevalence of smoking, geographical isolation, low socioeconomic status, low literacy, lack of 
awareness of health risks related to lifestyle) contribute to challenges in addressing and managing 
the HNC burden in Appalachian Kentucky.  Therefore an effort needs to be made to identify and 
address the medical needs for HNCs in Kentucky, especially Appalachian Kentucky in order to 
plan educational, screening and prevention programs. To effectively plan such programs, it is 
important to first characterize the HNC population in the targeted region. The present study 
characterizes the HNC population at the University of Kentucky (UK) otolaryngology clinic and 
HNC clinic at the Markey Cancer Center. The University of Kentucky otolaryngology clinic and 
HNC clinic are considered tertiary care centers for cancer management. The HNC clinic is 
located in the Markey Cancer Center (MCC). The Markey Cancer Center is also Kentucky’s only 
National Cancer Institute (NCI) designated center. The Markey Cancer Center at the University 
of Kentucky is located in central Kentucky and serves a large number of patients around 
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Kentucky (both central and eastern) as well as some surrounding states .176 We believe that the 
sample collected through the present study is a close representation of trends seen across the state. 
The objective of the present study was to characterize the head and neck cancer 
population at the University of Kentucky over a 3-year period. Factors under study included 
trends in basic demographics, site of lesion, staging information, treatment types and tobacco use. 
Through this study we aimed to highlight the differences in trends between the Appalachian and 
non-Appalachian regions of Kentucky. Characterizing the HNC cancer population and 
highlighting differing trends between the two regions within Kentucky helps healthcare 
professionals identify high risk regions. Once identified, these high risk regions can be targeted 
for outreach, screening, education and health programs that promote increased awareness, early 
identification, and prevention of head and neck cancers.  
Specific aims 
Specific aim1: To characterize the distribution of head and neck cancers in the treatment seeking 
population at a University of Kentucky Markey Cancer Center in terms of site, stage, treatment 
trends, tobacco use and basic demographics in patients who sought treatment from January 2008 
to December 2010. 
Specific aim 2: To compare the distribution of head and neck cancers across Appalachian and 
non-Appalachian counties. Given the higher rate of tobacco use in Appalachian in comparison to 
non-Appalachian counties,169  we hypothesize that a larger number of patients identified at UK 
will belong to Appalachian counties. 
Specific aim 3: To compare stage of cancer at the time of detection across Appalachian and non-
Appalachian counties. Considering the limited access to medical facilities faced by the 
Appalachian population ,167,171,180 we hypothesize that the Appalachian population will have more 
advanced stage cancers at the time of their first visit. 
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Methods 
Following approval from the Institutional Review Board (IRB) at the University of 
Kentucky, data for the present study were obtained from the Kentucky Cancer Registry (KCR). 
KCR is part of the Surveillance, Epidemiology, and End Results (SEER) program, which is 
considered to be among the most accurate and complete population-based cancer registry 
programs in the world.179 Using the SEER site ICD-O-3 definitions, 181 cancers included in the 
final analysis included cancers of the lip (C00.0-C00.9), tongue  (C01.9-C02.9), salivary glands 
(C07.9-C08.9) , floor of mouth (C04.0-C04.9), gum and other mouth (C03.0-C03.9, C05.0-C05.9, 
C06.0-C06.9), nasopharynx (C11.0-C11.9),   tonsil (C090-C099), oropharynx (C100-C109), other 
oral cavity and pharynx (C14.0, C14.2-C14.8), larynx (C32.0-C32.9) and esophagus (C15.0-
C15.9). Since this was a single site study, only data from patients seen at UK were included. Data 
were collected for patients diagnosed from January 1, 2008 to December 31, 2010.  The following 
data were included in the final analysis; age at time of diagnosis, sex, county at diagnosis, site of 
lesion, AJCC stage at the time of diagnosis (American Joint Committee on Cancer -Sixth 
edition),182 type of treatment administered and tobacco use. Since the entire treatment seeking 
population in the three year period was included, there were no exclusions made based on age or 
number of primaries. One of the main objectives of this study was to investigate the differences in 
the above mentioned data between non-Appalachian and Appalachian counties for all included 
counties. Appalachian and non- Appalachian counties were determined according to the 
Appalachian Regional Commission classification. 
Statistical analysis 
Statistical analyses were completed using SPSS Ver.21. Main analyses included 
frequencies of the factors under study (i.e. age, sex, county, site of lesion, county- wise 
distribution, stage at the time of diagnosis, type of treatment administered and tobacco use). 
Using a Fisher’s exact test, comparisons were made between non- Appalachian and Appalachian 
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counties for the following factors: stage at the time of diagnosis, type of treatment administered 
and tobacco use. All tests are two sided with a 0.05 significance level. 
Results 
Basic demographics: A total of 476 patients were diagnosed with head and neck cancers at the 
University of Kentucky between January 1, 2008 and December 31, 2010. HNC were more 
prevalent in males as compared to females (3:1). The mean age of diagnosis was 58.61 years 
(SD=10.9) for males and 59.1 years (SD=13.1) for females. The most common type of HNC was 
squamous cell carcinoma which is similar to trends nationally and worldwide. The most common 
site of lesion was laryngeal cancers which made up 28% of the total sample (Table 3.1). In terms 
of tobacco use, 72% of the total sample was tobacco users (Table 3.2). Tobacco use included 
cigarette smoking and smokeless tobacco. When comparing treatments, a majority of patients 
(27%) received primary chemoradiation therapy (Table 3.3). 
Appalachian versus non-Appalachian comparisons: Comparisons were made with respect to 
total number of people diagnosed, stage at the time of diagnosis, treatment type and tobacco use 
between the Appalachian and non-Appalachian population. A total of 45 Appalachian counties 
and 22 non- Appalachian counties were included in the final analyses.  Appalachian and non- 
Appalachian counties were determined based on the Appalachian Regional Commission (ARC) 
classification.183 
The number of people diagnosed between January 1st 2008 and December 31st 2010 was 
higher in Appalachian counties (n=278) as compared to non- Appalachian counties (n=198). 
There were a higher number of patients diagnosed with advanced stage disease (Stage III-IV) in 
Appalachian counties (n=160) as compared to non- Appalachian counties (n=135).  However, 
when compared to the total population under study, the percentage of patients diagnosed with 
advanced disease was higher in non-Appalachian regions as compared to Appalachian regions. A 
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Fisher’s exact test was performed to analyze if there was a difference in the number of people 
diagnosed with late stage HNC in Appalachia as compared to non- Appalachian regions. Results 
showed that there was a significant difference between the Appalachian and non- Appalachian 
population (Table 3.5). The number of people who received multi-modality treatments was larger 
in Appalachian Kentucky as compared to non- Appalachian Kentucky; however these numbers 
were not statistically significant (Table 3.6). Tobacco use was comparable in Appalachian and 
non- Appalachian counties (72%) (Table 3.2).  
Discussion 
The present study was a single center hospital based study with the objective of 
characterizing the head and neck cancer population at the University of Kentucky over a 3-year 
period.  Data from the present study serves as preliminary data to investigate differences seen in 
Appalachian and non- Appalachian Kentucky, at a single tertiary care center in urban Kentucky. 
We propose to perform a larger study which includes state-wide data to further highlight the HNC 
burden in Appalachian Kentucky.   
According to the recent population census, non- Appalachian Kentucky is roughly three 
times more populated then Appalachian Kentucky 184 Despite this difference in population, the 
present study showed a higher number of patients with HNC in Appalachian Kentucky compared 
to non- Appalachian Kentucky. An important risk factor for HNC, smoking rates were 
comparable between Appalachian and non- Appalachian counties. However, an important factor 
that was not assessed was alcohol consumption in combination with smoking. Alcohol 
consumption in addition to smoking increases the risk for HNC by tenfold .27,28 This is a 
limitation which needs to be addressed for future studies. In terms of total numbers, Appalachian 
Kentucky also showed a higher number of patients diagnosed with advanced stage disease as 
compared to non- Appalachian Kentucky. However, when compared to the total population under 
study, for Appalachian and non- Appalachian regions included in the present study, non- 
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Appalachian regions showed a higher percentage of patients diagnosed with advanced stage 
disease.  This is possibly because majority of patients diagnosed with HNC belong to Fayette 
county; an urban county, which is also where UK is located.  This is a limitation since data from 
the entire state of Kentucky were not included. Despite this limitation, higher numbers of patients 
from Appalachia were seen at an urban tertiary care center in Kentucky (University of Kentucky) 
as compared to patients from non- Appalachian regions.  These numbers continue to highlight the 
elevated HNC burden in Appalachia. The elevated number of patients diagnosed with HNC and 
the advanced disease stage add to the cost burden of the disease in an already financially 
compromised population. 
The unique health issues faced by the Appalachian population in Kentucky have long 
been a topic of discussion. Appalachian Kentucky’s ‘All Cancer Rate’ is 17% higher than that of 
the national rate. 185 The National Cancer Institute (NCI) has recognized Appalachians as a 
population with severe cancer disparities.180 Some of the issues that have been identified to 
contribute to these health disparities include lower levels of literacy and low socioeconomic 
status. 186 A study by Elnicki et al. listed lack of knowledge about prevention (51%) and cost 
(36%)  as the top two patient perceived barriers to seeking healthcare in Appalachia .172 The 
geographic isolation of Appalachia further compounds the issue of ease of access to standard 
healthcare. The problem of access to health care services is magnified in rural areas that are 
remote and exist well outside urban boundaries where transportation is limited .172,186  
To complicate matters further, problems related to health disparities in Appalachia are 
not limited to socioeconomic, geographic or environmental factors. Unfortunately problems 
related to health disparities in Appalachia are deeply rooted in the Appalachian culture and the 
attitudes towards seeking healthcare in general. Perceptions of the Appalachian population 
towards cancer have been the topic of various studies as well. 166,171,186 People in Appalachia 
believe that contracting cancer is inevitable, thus ignoring the role of prevention. 187 Most 
Appalachians have a fear of doctors and do not seek medical help when require. 187 Since most 
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Appalachians are economically challenged, missing work to seek medical help is not an option. 
187  
For the past few years, several screening programs have been implemented for colorectal, 
cervical, breast, ovarian and prostate cancers. One example of a successful screening program for 
Kentucky is the colorectal cancer screening program.  Ten years ago, Kentucky had the second 
lowest screening rate in the country and had one of the highest incidences of CRC in the country. 
188 However, with joined efforts from Colon Cancer Prevention Project, American Cancer 
Society, the Kentucky Department for Public Health, the Kentucky Cancer Program, the 
Kentucky Cancer Registry and a few other organizations within the Kentucky cancer consortium, 
the incidence rate for colorectal cancer has reduced by 25 percent and the death rate has reduced 
by 28 percent .188 From barriers listed above which include economic, environmental, 
geographical barriers and a negative attitude towards seeking healthcare; it is apparent that 
outreach is the need of the hour. Consequently, outreach programs need to focus on education and 
prevention, early identification and screening. Screening programs also must be affordable. HNC 
screening, protocols and instrumentation are relatively affordable especially when compared to 
those required for colorectal, prostate, breast, cervical or ovarian cancers .179 Ideally, screening, 
educational and prevention programs can be propagated by healthcare professionals known to the 
community, such as primary healthcare providers (PCP). To this end, PCPs need to be educated 
and trained on HNC screening procedures, knowledge on prevention of HNC and the importance 
of early detection and intervention. Subsequently, educational programs for HNC screening, 
prevention and early detection and intervention can be expanded to community health workers 
such as nurses, dental hygienists and community aid workers. The idea is to provide easy access 
to patients closer to their homes where they do not need to arrange finances for transportation. 
Reaching out to patients through means within the community would certainly help in 
overcoming barriers of geographical isolation. A low cost screening program also reduces the 
financial burden of a physician’s visit. We recognize that issues related to increasing HNC 
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incidence in Appalachian Kentucky extend beyond the low socioeconomic status of Appalachian 
Kentucky and the lack of access to healthcare. A general change in attitude towards seeking 
healthcare in the Appalachian population is just as vital. Implementation of screening, educational 
and prevention programs would only be the first of many steps towards tackling a serious 
problem faced by the people of Appalachian Kentucky, one that should no longer be ignored. 
The next chapter will provide the reader with a detailed description of stage 2 of the 
present dissertation study. Individuals irradiated for laryngeal cancers identified from stage 1 
were recruited for stage 2 of the study. Stage 2 involved characterizing vocal function in 
individuals irradiated for laryngeal cancers.  
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CHAPTER 4: STUDY 2 
Study title: A study of vocal function using a multi-dimensional assessment battery in adults 
irradiated for laryngeal cancer 
Chapter 4 describes Stage II of the dissertation study in detail. As described in previous 
chapters, vocal function is best assessed using a multidimensional assessment battery which 
encompasses physiological and psychosocial factors of voice production. The objective of the 
present study was to characterize vocal function in adults irradiated for laryngeal cancers using 
the five domains of voice assessment. The present irradiated study population was also matched 
in age, sex and pack years of smoking to a control group of adults without history of irradiation 
for head and neck cancers. The next few sections inform the reader on background, study 
methodology and results of the present study. This chapter also includes a detailed discussion of 
the study findings. 
Background 
Primary radiation therapy (XRT), with or without chemotherapy, has proven to be an 
effective curative modality in the treatment of both early and advanced laryngeal cancers. Early 
laryngeal cancers are often treated with radiation therapy alone,1,189 while advanced laryngeal 
cancers are treated with a combination of radiation therapy and chemotherapy.32 Since the 1990s, 
an increasing number of patients are being treated with primary radiation therapy, with or without 
chemotherapy.31 The intent of treating laryngeal cancers in this manner is to preserve laryngeal 
structure and function while eliminating disease.31 However, a number of post-treatment studies 
have demonstrated poor voice and swallowing outcomes as a result of radiation toxicity. Voice 
and swallowing dysfunction following radiation are indicators that preservation of laryngeal 
structure is not necessarily translating into preservation of laryngeal function for these patients. 
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These voice and swallowing changes are known to persist over long periods of time and in some 
cases are permanent.  
A number of studies have documented the effects of radiation on vocal function.1,9,30,32 
However, these studies have often used limited outcome measures which do not capture the 
multidimensional nature of vocal function. Normal voice production is dependent upon the 
physiological and psychosocial aspects of voice use. Physiologically, normal voice production 
requires an interaction among the three subsystems of voice production: respiration, phonation 
and resonance. Psychosocial factors reflect the individual’s voice use with respect to activities of 
daily living. To incorporate these physiological and psychosocial domains to provide a holistic 
description of an individual’s vocal function, voice production should ideally be assessed using a 
multidimensional assessment battery.33 Hirano190 stated, “Voice is multidimensional in nature, so 
we need a set of tests to evaluate function in its entirety.”  This sentiment was reiterated by Titze 
et.al.,who stated, “Diagnostic hypotheses should not be made on basis of one test or measure 
because one cannot look at an isolated phenomenon without running the risk of misinterpreting 
the results”. 191,192 Multidimensional assessment of voice helps overcome the limitations of any 
one assessment type. 191   
Select assessment parameters within these domains have been recommended by 
researchers in the field of voice disorders based on their reliability and validity measures. The 
measures recommended through research were used in the present study. The five domains of 
voice assessment include stroboscopic (laryngeal visualization), acoustic, aerodynamic, patient 
self-report and auditory-perceptual parameters.33  Study parameters within the five domains of 
voice assessment are presented in Table 4.1. The next section informs the reader on clinical 
findings in select parameters of voice assessment following XRT. The findings are divided 
according to the parameters within each of the five domains of voice assessment. 
  
45 
 
Auditory-Perceptual findings: Auditory perceptual findings from previous studies report varied 
vocal symptoms. These studies used an informal scale for perceptual assessment and not a 
standardized scale such as the GRBAS or CAPE-V.51,53 Perceptually patients often present with 
hoarseness, decreased volume, increased strain and persistent voice changes.8,13,81  
Voice related quality of life: A recent study by Karlsson, et al. (2016) 17 that investigated voice-
related quality of life measures in patients with early and advanced laryngeal cancers revealed no 
significant differences between pre-radiation and post-radiation scores one year after completion 
of treatment. These results indicate that the deterioration in voice quality perceived by the patient 
as a result of laryngeal cancer did not improve after completion of treatment to eliminate laryngeal 
cancer.17 A study that investigated voice problems as a result of radiation for early glottic cancers 
demonstrated that 87.8% of the patient sample reported their voice as being abnormal, ranging 
from slight to moderate dysfunction.82 
Acoustic measures: The majority of studies showed that radiation therapy had a negative impact 
on voice quality, as revealed by increased perturbation and noise measures. Voice quality was 
gradually found to improve over 3-6 months post-radiotherapy. However, none of the post-
treatment perturbation values fell within the normal range. 78-80 
Aerodynamic measures: McGuirt et al. (1994)12 revealed mean laryngeal airway resistance (LAR) 
values 4.5 times greater than normal values (mean=177cmH2O/L/s) in patients who had been 
irradiated for T1a glottic cancer. These LAR values are comparable to those in a study by Aref 
(1997)30 who found that none of 12 patients attained normal aerodynamic measures. Increased 
airflow rates in patients who had undergone radiotherapy (n=6) were also observed in a study by 
Tamura (2003)79 in which mean airflow rates of 165 cc/s were measured. Increased aerodynamic 
resistance values reflect the signs of supraglottic hyperfunction seen stroboscopically and are also 
indicative of issues with reduced glottal valving. 
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Laryngeal imaging (Stroboscopic findings): In a detailed study performed by Lehman et al 
(1988),77 significant abnormalities were seen on stroboscopic analysis in patients irradiated for 
stage I glottic cancers. Around 60% of patients showed irregular vocal fold closure, 65% 
increased supraglottic activity, 85% irregular vibratory margins, 80% shorter closure phase and 
85% irregular phase symmetry. The stroboscopic finding consistent across the group was 
decreased vibratory amplitude not only on the treated vocal fold but also on the non-diseased 
fold. These findings were consistent with those in a study by McGuirt et al. (1994)12 that reported 
decreased mucosal wave on both the treated and non-diseased fold. In addition, subjects showed 
signs of muscle tension dysphonia, ventricular phonation, and partial antero-posterior 
compression. 
 From the study findings described in the previous section, it is clear that multiple 
domains of vocal function are affected as a result of radiation toxicity to the laryngeal 
mechanism. To this end, in the present study we characterized vocal function after radiation 
therapy for laryngeal cancers as assessed holistically by all five domains of voice assessment. 
The next section describes aims specific to stage II of the dissertation. 
Specific aims 
Specific aim 1: To characterize vocal function in subjects who have been treated with radiation 
therapy for laryngeal cancers as determined by stroboscopic imaging; high-speed digital laryngeal 
imaging; acoustic, aerodynamic, and perceptual analyses; and patient self-report measures. 
Previous studies have reported post-radiation therapy deterioration of select parameters within 
the five domains of voice assessment. None have included all five domains in the same study.  We 
hypothesize that the present study results will follow similar trends.1,12,30,77,193 
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Specific aim 2: To compare vocal function in individuals who have been treated with radiation 
therapy with age, sex and pack-years matched controls as determined by stroboscopic imaging, 
high-speed laryngeal imaging, acoustic, aerodynamic, perceptual and patient self-report 
measures.  Previous studies have reported deterioration in vocal function after radiation 
therapy.1,12,30,77,193 However, additional factors such as tobacco smoking and age-related changes 
have been known to affect vocal function adversely as well.194,195 To account for these factors, we 
matched subjects in the control group based on age, sex and tobacco use. We hypothesize that the 
present study will show clinically worse values of vocal function in the irradiated group as 
compared to the control group. 
Methods 
Participants for Stage II were recruited from the multidisciplinary head and neck cancer 
clinic at the Markey Cancer Center (University of Kentucky) following approval from the 
Institutional Review Board (IRB) at the University of Kentucky (UK). A sample size of 20, with 
10 participants in each group was required to achieve 80% power to detect a difference of 12 
points in VHI between healthy and irradiated individuals at a significance level of 0.05.16,196 Stage 
II was designed as a cohort study. 
Participants 
 After completion of informed consent, 18 participants were included in the study based 
on inclusion and exclusion criteria. Participants in the radiation therapy group met the following 
inclusion criteria: adults over 18 years of age, previously irradiated for laryngeal cancer (with or 
without chemotherapy), hearing levels appropriate to follow directions, and deemed cancer-free 
at the time of study recruitment. Participants had to have completed XRT at least 6 months prior 
to study participation. Presence of vocal fold paralysis or surface vocal fold pathology at the time 
of study recruitment constituted exclusion from the study. Participants in the control group met 
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the following inclusion criteria: adults over 18 years of age, former/current/non-smokers, hearing 
levels appropriate to follow directions and no history of head and neck cancer. Presence of 
surface vocal fold pathology, vocal fold paralysis or neurological disorder constituted exclusion 
from the study. Participants in the control group were recruited based on age, sex and pack years 
of smoking parameters as compared to the radiation group. 
Assessment battery 
Participants in both groups underwent the same multidimensional vocal assessment 
battery. The battery included assessment protocols belonging to the five domains of voice 
assessment. A checklist for the assessment battery is available in Appendix I. The five common 
domains of voice assessment are: auditory-perceptual measures, patient self assessment, acoustic 
analyses, aerodynamic analyses, and laryngeal imaging or visual perceptual assessments. 
Outcome measures and their normative values are available in Table 4.1. Outcome measures are 
listed below with reference to each domain of voice assessment.  
1) Auditory- Perceptual assessment: Consensus Auditory Perceptual Evaluation of Voice 
(CAPE-V- Appendix II) was utilized. Blinding: Audio samples of patient’s voices reading the 
rainbow passage (Appendix III) were presented to a licensed and certified speech-language 
pathologist with over 40 years of clinical experience in the field of voice disorders. The 
assessor was blinded to group assignments. 
2) Patient self-assessment: Voice Handicap Index (Appendix IV) was utilized. Total scores and 
domain specific scores (Physical, Functional, Emotional) were included for final analysis. 
3) Acoustic analyses: The Multidimensional Voice Profile (MDVP) and Analysis of Dysphonia 
in Speech and Voice (ADSV) were utilized. Specific measures included jitter, shimmer, noise 
to harmonics ratio (NHR), maximum phonation time (MPT) and pitch range  for MDVP; and 
Cepstral Spectral Index of Dysphonia (CSID) for ADSV stimuli.197 CSID included sustained 
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vowel and sentence stimuli. Sentences included easy onset, voiceless plosive, all voiced and 
hard glottal attacks.  
4) Laryngeal imaging/visual perceptual assessment: Measures included were laryngeal 
stroboscopy and high speed laryngeal imaging. Stroboscopic and high speed features were 
rated on a scale (Appendix V). Stroboscopic and high speed parameters include glottic closure, 
mucosal wave, amplitude of vibration and phase symmetry. Ratings were performed by a 
licensed and certified speech-language pathologist with over 40 years of clinical experience in 
the field of voice disorders. The speech-language pathologist was blinded to group 
assignments.  
Instrumentation 
1) Laryngeal stroboscopy: Laryngeal stroboscopy was performed using the Kay Elemetrics 
Rhino-Laryngeal Stroboscope – (Model RLS 9100 B, Halogen lamp: 150 watts, Xenon lamp: 120 
watts, frequency range: 60 Hz – 1000 Hz, laryngeal microphone), a Kay Elemetrics 70 degree 22 
rigid scope (Model 9106, total length: 252 mm), Kay distal endoscope, and a C-mount camera 
(Panasonic 3CCHD).  
2) High speed digital imaging: For the HSDI recordings, a KayPentax high-speed system model 
9710 was used. Images were recorded at 4000 frames/s for a maximum duration of 4 seconds 
with a spatial resolution of 5123256 pixels. A 300W Xenon light source was used  
3) Acoustic analysis: For acoustic assessment, the Computerized Speech Lab Model 4500 by 
KayPentax was used with a hand-held microphone (mouth-to-microphone distance = 3 inches) 
[System Requirements: Analog Inputs: 4 channels: two XLR and two phono-type, 5mV to 10.5V 
peak-to-peak, adjustable gain range >38dB, 24-bit A/D, Sampling Rates: 8,000-200,000Hz, 
THD+N: <-90dB F.S. Frequency Response (AC coupled): 20-22kHz +.05dB at 44.1kHz. Digital 
Interface: AES/EBU or S/P DIF format, transformer-coupled. Software Interface: ASIO and 
MME. Computer Interface: PCI (version 2.2-compliant), PCI card; 5.0" H x 7.4" W x 0.75" D 
(half-sized PCI card). Analog Output: 4 channels, line and speaker, headphone output, channels 1 
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& 2 provide line & speaker outputs. Physical: 4" W x 8.25" H x 12.5" D, 4 lbs. 12 oz., 45 watts, 
speaker, and microphone (Shure SM-48 or equivalent, XLR-type)]. 
4) Aerodynamic analysis: The Phonatory Aerodynamic System Model 6600 by KayPentax was 
used for the aerodynamic measurements (300 ml pneumotachograph - System requirements same 
as CSL model 4500). Airflow measures were taken using an airflow mask and a 
pneumotachograph, which uses the principle of differential pressure across a known resistance to 
estimate airflow rate. 
Statistical analysis 
Statistical analyses were performed using SPSS ver.22. Statistical analyses included 
descriptive statistics, frequencies and comparisons between the radiation therapy (RT) and control 
groups. Comparisons for continuous variables between the two groups were performed using 
independent sample t-tests and Mann-Whitney U-tests depending on normality of distribution. 
Continuous variables included CAPE-V measures, VHI scores, acoustic measures (jitter, 
shimmer, Noise to Harmonic Ratio, Maximum Phonation Time, pitch range and CSID measures). 
Comparisons for non-continuous variables between the two groups were performed using a 
Fisher’s exact test. Non- continuous variables included stroboscopic and high speed parameters. 
Significance levels were set at 0.05. 
Results 
Descriptive statistics: A total of 18 participants were recruited for the study (RT=10, control=8). 
The RT group consisted of seven males and three females, and the control group consisted of six 
males and two females. The mean age of participants in the RT group was 66.1 years (standard 
deviation:12.96) and the mean age of participants in the control group was 55.5 years (standard 
deviation: 13.8). In terms of smoking status, the RT group consisted of six former smokers, two 
current smokers, and two non-smokers. Nine participants in the RT group had a history T1 glottic 
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cancer and one participant had a history of T2 supraglottic cancer. The control group consisted of 
three former smokers, four current smokers and one non-smoker. In terms of smoking habits, the 
mean pack years in the RT group was 37.9 years (standard deviation: 38.91) and control group 
was 41.38 years (standard deviation= 26.62). For the RT group, time from completion of 
radiation therapy ranged from 24 – 84 months. Descriptive statistics for participant demographics 
are available in Table 4.2.  
Prior to comparisons of vocal function parameters, the two groups under study were 
compared for age, sex and pack years of smoking. The two groups were closely matched in sex 
distribution. Results from independent sample t-tests showed no significant differences between 
the two groups in terms of age (p= 0.118) or pack years of smoking (p= 0.825).  
Results from continuous variables: The  two groups differed significantly for; CAPE- V 
parameters of overall severity (p=0.11) (Table 4.4), loudness (p=0.012) (Table 4.5), breathiness 
(p=0.001) (Table 4.4), roughness (0.008) (Table 4.4) and strain (p=0.007) (Table 4.5), Voice 
Handicap Index-Physical domain (p= 0.036) (Table 4.7), pitch range (p= 0.045) (Table 4.10) and 
mean peak air pressure/PSub (p= 0.01) (Table 4.13) . 
Overall abnormal clinical values were seen in the RT group as observed in their mean 
scores for CAPE-V overall severity (29.4) (Table 4.3), CAPE-V loudness (29.9, SD: 13.74 ) 
(Table 4.3), CAPE-V breathiness (32, SD: 12.4) (Table 4.3), CAPE-V roughness (31.7, 
SD:15.48) (Table 4.3) and CAPE-V strain (36.1, SD: 12.7) (Table 4.3); overall VHI scores (22.6, 
SD: 13.5) (Table 4.6); jitter percentage (2.14) (Table 4.9), shimmer dB (0.68) (Table 4.9), noise 
to harmonics ratio (0.209) (Table 4.9), CSID /a/ (23.79) (Table 4.9), CSID for easy onset stimulus 
(18.62) (Table 4.9), CSID for voiceless plosive stimulus (19.43) (Table 4.9), CSID for hard 
glottal attack stimulus (19.59) (Table 4.9); Psub (9.08, SD: 2.41) (Table 4.12), laryngeal airway 
resistance (74.69, SD: 84.6) (Table 4.12) and phonation threshold pressure (5.9, SD:3.25) (Table 
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4.12). Means and standard deviations for all continuous variables under study are available in 
Tables 4.3 to 4.12.  
Results from non-continuous variables: Clinically abnormal findings were seen across majority 
of stroboscopic and high speed parameters under study for both groups. High speed laryngeal 
imaging could not be performed on two participants from the RT group and one participant from 
the control group due to participant difficulty tolerating the presence of a rigid endoscope. 
However, the RT group showed a higher percentage of participants with abnormal stroboscopic 
and high-speed parameters. Percentage of participants who demonstrated abnormal stroboscopic 
and high-speed parameters is displayed in tables 4.15 and 4.17 respectively. The control group 
showed a higher percentage of abnormal findings only for the parameters of phase symmetry 
(Table 4.15). However, the two groups under study only showed a statistical significant 
difference for amplitude of vibration for stroboscopic examination (p=0.009) (Table 4.16). No 
significant differences were observed between the two groups for any of the high speed 
parameters (Table 4.18). 
Discussion 
Previous studies have demonstrated that radiation therapy negatively affects voice 
quality;9,30,77,81 however these studies have examined limited voice outcome measures. As a result 
it is difficult to characterize vocal function issues following radiation therapy in a comprehensive 
manner. The present study confirmed findings from previous studies since it demonstrated that 
patients exhibited abnormal vocal function across various voice parameters following radiation 
therapy. Interestingly, participants in the radiation group were 24-84 months post-completion of 
radiation therapy and continued to exhibit clinically abnormal values in voice parameters, further 
highlighting the long-term and in some cases permanent deleterious effects of radiation toxicity 
on voice quality. However, the aim of the present study was to characterize vocal function 
53 
 
beyond simply one parameter by examining the five domains of voice assessment. Participants in 
the RT group were also compared to participants who were matched in terms of sex, age and 
smoking habits to account for changes to the vocal mechanism that take place as a result of these 
factors. The results from the present study are discussed in detail in the next section with 
reference to each of the domains of voice assessment.  
Domain I- Auditory perceptual measures (Tables: 4.3,4.4,4.5) 
The present study compared CAPE-V scores between the two groups under study. The 
assessor for CAPE-V is a licensed and certified speech-language pathologist with over 40 years 
of experience in the field of voice disorders. The assessor was blinded to group assignments. 
CAPE-V scores in the radiation therapy group were consistently worse as compared to the control 
across all CAPE-V parameters except for pitch (overall severity, loudness, breathiness, roughness 
and strain). For parameters of overall severity, roughness and strain, CAPE-V scores were in the 
clinically abnormal range for both groups, but were higher in the RT group, which is indicative of 
a greater degree of dysphonia. The control group showed mild dysphonia across overall severity, 
roughness and strain, and the RT group showed moderate dysphonia across the same parameters. 
Similar findings were reported in studies by Bergstorm, et.al, Hocevar, et.al and Sjoren, et.al.8,13,81 
Scores for loudness and breathiness were within normal limits for the control group, whereas the 
RT group showed scores that demonstrated moderate levels of dysphonia. Statistically, the groups 
differed across all parameters except for pitch. These findings demonstrate that the voice quality 
of participants who had been irradiated sounded distinctly abnormal and moderately dysphonic to 
an experienced listener as compared to a control group of participants who were matched in age, 
sex and pack years of smoking. 
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Domain II- Patient self assessment (Tables: 4.6,4.7,4.8)  
The present study compared Voice Handicap Index scores between the two groups under 
study. Participants in the RT group had higher total scores (mean: 22.6, SD: 13.5) as compared to 
the control group (mean:11.63, SD: 12.68) indicative of a greater level of voice handicap. 
However, in the RT group, these scores were in the clinically abnormal range only for the 
physical domain of voice handicap (mean: 13.3, SD: 9.4).47 Each of the domain scores for 
participants in the control group was within clinically normal limits. The physical domain of the 
voice handicap index represents self-perceptions of laryngeal discomfort and voice output 
characteristics.47 Findings of reduced scores on voice-related quality of life were consistent with 
findings on studies by Karlsson, et.al and Cohen, et.al.17,193 These results indicate that individuals 
continue to experience challenges related to voice use following radiation therapy. Participants in 
the RT group consistently rated high levels of impairment on the following statements: 
1) I feel as though as I have to strain to produce voice 
2) I use a great deal of effort to speak 
3) My voice sounds creaky and dry 
4) The sound of my voice varies throughout the day 
5) The clarity of my voice is unpredictable 
6) My voice gets worse in the evening 
These findings are reflected in the CAPE-V scores, as voices of participants in the RT group were 
described as having increased roughness, increased breathiness and increased strain. 
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Domain III- Acoustic analysis (Table 4.9,4.10,4.11) 
Comparisons were made between two groups for measures of jitter, shimmer, noise to 
harmonics ratio, pitch range, maximum phonation time and CSID measures. The RT group 
demonstrated clinically abnormal values on sustained vowel /a/ for measures of jitter (mean: 2.14, 
SD: 2.61), shimmer (mean: 0.68, SD: 87) and Noise to Harmonic Ratio (Mean: 0.209, SD: 0.21). 
These values were within clinically normal limits for the control group. For connected speech and 
sustained phonation when analyzed using the Analysis of Dysphonia for Speech and Voice 
(ADSV), CSID (Cepstral Speech Index of Dysphonia) values were higher in the RT group across 
all sentence types (easy onset- EOS, all voiced- AVS, voiceless plosives- VPS and hard glottal 
attacks-HGAS) as compared to the control group. These values were also in the clinically 
abnormal range for all parameters with the exception of VPS in the RT group. These parameters 
were within normal limits in the control group. Pitch range in the RT group was also lower as 
compared to the control group. Average maximum phonation times between the two groups only 
differed by three seconds. Values of increased perturbation measures are consistent with findings 
of studies by Tamura et.al and Wedman, et.al.78,79 However, even though these values fell within 
the clinically abnormal range for the RT group, the only measure that demonstrated statistically 
significant differences between the two groups was pitch range (p= 0.045). Elevated perturbation, 
noise measures and CSID values further describe the dysphonia perceived in the auditory-
perceptual analysis. Increased perturbation, noise and CSID measures can be associated with 
increased roughness and breathiness heard on the auditory-perceptual analysis. An increase in 
these measures is also reflected in the patients’ perception of their voices on the VHI when they 
describe their voices as sounding “creaky or dry.” 
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Domain 4: Aerodynamic measures (Tables 4.12,4.13,4.14) 
Aerodynamic measures of mean peak air pressure, laryngeal airway resistance, mean 
airflow during voicing and phonation threshold pressure were compared between the two groups. 
Clinically abnormal values were seen in the RT group for measures of mean peak air pressure 
(mean: 9.08, SD: 2.41), laryngeal airway resistance (mean: 74.69, SD: 84.7) and phonation 
threshold pressure (mean: 5.93, SD: 3.25). Findings of elevated peak pressure and airway 
resistance values are consistent with findings of studies by McGuirt, et.al and Tamura, et.al.12,79 
These values were within normal limits in the control group. The control group showed clinically 
abnormal values for airflow rate (mean: 0.205, SD: 0.29); average airflow rate was within normal 
limits for the RT group. Although these values were in the clinically abnormal range, the only 
parameter that demonstrated statistically significant difference between the two groups was Psub 
(p=0.01). Increased resistance, Psub and phonation threshold pressure values are suggestive of the 
presence of increased effort and hyperfunctional voice use in the RT group .198 The increase in 
Psub and LAR values is also indicative of increased stiffness offered by edematous vocal 
folds.65,198 These elevated clinical values are reflected in the strain scores of the CAPE-V, as well 
as in the responses of participants on select VHI items (“I feel as though I have to strain my 
voice,” “I use a great deal of effort to speak”). 
Domain 5: Visual perceptual measures or laryngeal imaging (Tables 4.15,4.16,4.17,4.18) 
Laryngeal imaging was performed using laryngeal stroboscopy and high speed laryngeal 
imaging. Visual perceptual ratings were performed by a licensed and certified speech- language 
pathologist with over 40 years experience in voice disorders. The assessor was blinded to the 
groups under study. Comparisons on both methods of visualization were made on parameters of 
glottic closure, mucosal wave, amplitude of vibration, phase asymmetry and presence or absence 
of hyperfunction. Qualitative assessments were made on the overall appearance of the laryngeal 
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mechanism (dehydrated appearance, edema) and true vocal folds (erythema, edema, 
hypervascularity or combination of erythema, edema and hypervascularity) considering the 
structural damage to the laryngeal tissues following RT, as well as exposure to tobacco and age 
related changes. Between the two groups, the RT group demonstrated a higher percentage of 
participants with clinically abnormal findings for mucosal wave (90%), amplitude of vibration     
(100%) and phase symmetry (70%). Both groups showed a high percentage of participants with 
presence of hyperfunction (100% in both groups). The overall appearance of the larynx was 
judged as being abnormal (dehydrated and erythematous) in 70% percent of participants in the 
RT group as compared to 37.5% percent (erythema only) in the control group. Similar findings 
were noted for appearance of the true vocal folds, where eighty percent of the participants in the 
RT group were judged as having some abnormality of the true vocal folds and these abnormal 
findings were noted on the primary cancer site as well as on the vocal fold unaffected by cancer. 
The abnormal findings of overall laryngeal appearance and changes on the unaffected vocal fold 
as a result of XRT further highlight the collateral damage caused due to radiation toxicity. These 
findings are consistent with studies by Wedman et. al,78 Tamura, et.al79 and Mintz, et.al.9  
High speed laryngeal imaging was found to be a more effective tool for judging vocal 
fold vibratory parameters. There was a decrease in abnormal findings when judging vocal fold 
pliability (mucosal wave and amplitude) in both groups on high speed imaging. There was 
increase in abnormal findings in RT group for glottic closure judgement using high speed 
imaging. The overall level of dysphonia was higher in the RT group, making stroboscopic 
parameters less reliable due to tracking errors.199 This is consistent with findings in previous 
studies which have favored the use of  high speed laryngeal imaging in judging vocal fold 
vibratory parameters in patients with highly dysphonic voices.199 
 As demonstrated by the results above, one or more parameters in each domain of voice 
assessment was found to be clinically abnormal in the RT group. The control group demonstrated 
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abnormal findings for the domains of laryngeal imaging (100% showed hyperfunction) and one 
parameter of the aerodynamic domain (airflow rate). The present study demonstrates the effect of 
radiation toxicity on vocal function holistically. The present study shows that physiological and 
psychosocial domains of vocal function are affected following XRT and continue to be affected 
for several years after completion of XRT. Considering that XRT has a significant negative 
impact on vocal function, voice rehabilitation following XRT is important, which is the focus of 
the next chapter.  
Limitations 
For our present study, we were not successful in accruing the target sample size. 
However, our groups were well matched in age, sex and pack years of smoking. Our study had 
certain limitations that need to be addressed. Since we were addressing issues of vocal function as 
a result of XRT, we did not perform pre-XRT voice assessments. However, pre-XRT assessments 
would be helpful in identifying the deterioration in vocal function as a result of laryngeal cancer 
itself and then comparing these deficits with those seen as a result of XRT to gain a more holistic 
picture of the individual’s experience. Another limitation was the variation in the RT group itself 
between early and late stage cancers. A majority of the group was early stage glottic cancers and 
our participant with advanced cancer had a history of supraglottic cancer. For future studies, 
equally distributed groups in terms of stage and site are suggested within groups. Stratification of 
site and stage is also suggested since individuals with advanced laryngeal cancers also receive 
chemotherapy. Future studies may seek to identify changes in vocal function as a result of 
chemotherapy compared to XRT alone.  
 The next chapter focuses on stage 3 of this dissertation, which consisted of investigating 
the efficacy of an evidence based voice rehabilitation method (Vocal Function Exercises) in 
adults who had undergone XRT.  
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CHAPTER 5: STUDY 3 
Study title: Investigating the efficacy of Vocal Function Exercises in improving voice production 
in adults irradiated for laryngeal cancers 
Chapter 5 describes Stage III of the dissertation study in detail. As described in previous 
chapters, vocal function is negatively affected following radiation therapy for laryngeal cancers. 
As observed in previous studies, and as demonstrated in Stage II of this dissertation, multiple 
dimensions of vocal function are affected as a result of radiation therapy. These changes are 
chronic in most cases and can cause significant voice-related quality of life issues. Though post-
radiation voice problems are a well-established clinical entity, there is an observable dearth of 
evidence into investigating the rehabilitation of these voice disorders.  At present, there is no 
standardized approach to voice rehabilitation in patients irradiated for laryngeal cancers. The 
objective of the present study was to investigate the efficacy of a systematic evidence-based 
approach to improving vocal function following radiation therapy for laryngeal cancers. The next 
few sections inform the reader on background, study methodology, and results of the present 
study. This chapter also includes a detailed discussion of the study findings. 
Background 
 The curative role of radiation therapy (XRT) in the treatment of laryngeal cancers is well 
documented. Since the 1990s, increasing numbers of patients with laryngeal cancers have been 
treated primarily with radiation therapy, with or without chemotherapy, with the intent of 
preserving laryngeal structure and function. Early laryngeal cancers can be treated with XRT 
alone, while advanced laryngeal cancers are treated with a combination of chemotherapy and 
radiation therapy. 2,3 However, collateral damage to the laryngeal and oral structures caused by 
radiation toxicity absent chemotherapy is a well-documented clinical entity.6-9 These prolonged, 
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and in some cases, permanent voice and swallowing problems post-radiation are indicators that 
preserving laryngeal structure is not translating into preserving laryngeal function.  
Radiation damage to the larynx results in edematous and dehydrated tissues, leading to 
excessive compensatory compression of laryngeal structures during phonation, thus affecting 
vocal fold vibratory characteristics.8,10-12 Another characteristic feature of radiation toxicity is 
delayed onset of injury.10 Consequently, following these acute changes to the laryngeal 
mechanism, ongoing negative changes occur as a result of radiation toxicity. Acute and long-term 
deterioration in voice quality post-radiation may lead to significant communication deficits in 
daily life or in some cases may result in loss of livelihood. Therefore, voice rehabilitation post-
radiation therapy is relevant consideration and warrants attention. Unfortunately, there is a 
paucity of research with respect to voice rehabilitation in the irradiated population. Only four 
studies have investigated the efficacy of voice therapy in post-radiated laryngeal cancer patients 
with no recommended standardized treatment.13-16 The two studies conducted in patients 
irradiated for early glottic cancers did not describe the type of voice therapy used; however the 
study did demonstrate that voice therapy was successful in improving perceptual voice quality 
and voice-related quality of life.15,16 Two other studies investigated the efficacy of voice therapy 
when utilized post-radiation for not only early but also advanced laryngeal cancers.13,14 In both 
studies, patients showed a greater improvement in voice quality as measured by auditory-
perceptual measures and voice-related quality of life as compared to a control group. The voice 
therapy interventions across these four studies, however, were varied and not specified. 
According to these publications, the authors used direct and indirect voice interventions, ranging 
from tasks such as breathing, relaxation, and posture adjustment to specific physiology-targeted 
phonation exercises. However, the studies do not assert whether or not one of these methods was 
more efficacious than the others. In addition, only two dimensions of vocal function – perceptual 
quality and voice-related quality of life self-assessment - were used to measure improvement in 
both studies, instead of a more comprehensive voice assessment method.  
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 Central to treatment approaches in the above studies was vocal hygiene (VH) counseling. 
13-16 However, results of outcomes research related to VH demonstrate that this form of therapy 
may be more effective when coupled with a more exercise-intensive physiologic voice therapy 
approach.20 The Vocal Function Exercise (VFE) program is one such evidence-based physiologic 
approach to voice therapy. VFEs include a series of isometric and endurance-based exercises 
aimed at strengthening laryngeal musculature, improving vocal fold vibratory characteristics, and 
balancing the three sub-systems of voice production: respiration, phonation and resonance.22 
Although VFEs have been employed successfully in treating a variety of voice disorders, the 
efficacy of this approach for improving voice quality in adults following laryngeal radiation has 
not been investigated.18,19,22,23 The success of VFEs with various voice disorders has led to the 
principal question of the present dissertation: 
Research question: Is the Vocal Function Exercise program efficacious in improving voice 
production in adults radiated for laryngeal cancers? 
The following specific aims were addressed in Stage III of the dissertation: 
Specific aims 
Specific aim 1:  To investigate the efficacy of Vocal Function Exercises (VFE) for improving 
voice production in adults irradiated for larynx cancers as demonstrated by change in pre- and 
post-intervention Voice Handicap Index scores. The present stage was designed as a Phase 2 
clinical trial with Voice Handicap Index being the primary outcome measure. Secondary outcome 
measures include laryngeal stroboscopy, high-speed laryngeal imaging, acoustic analysis, 
aerodynamic analysis and auditory-perceptual measures. Participants were randomly assigned to 
one of two groups: VFE and vocal hygiene (VFE+VH), and vocal hygiene (VH) alone. VH was 
used as the comparison treatment group since previous studies have utilized vocal hygiene as a 
treatment approach for patients irradiated for laryngeal cancers. We hypothesize that the VFE + 
VH group will demonstrate significantly greater improvement in pre- and post-treatment Voice 
Handicap measures as compared to the VH only group.    
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Specific aim 2: To investigate the efficacy of Vocal Function Exercises (VFE) for improving 
voice production in adults irradiated for larynx cancers as demonstrated by improvement in select 
parameters from the five domains of voice assessment. Outcome measures from the five domains 
of voice assessment include patient self- assessment, auditory-perceptual measures, acoustic 
analysis, aerodynamic analysis, laryngeal stroboscopy and high-speed laryngeal imaging. We 
hypothesize that the VFE + VH group will demonstrate a larger proportion of participants with 
an improvement across all five domains as compared to the VH only group.    
The next section describes our study methodology in detail which addresses the specific 
aims stated above. 
Methods 
Participants for Stage III were recruited from the multidisciplinary head and neck cancer 
clinic at the Markey Cancer Center (University of Kentucky) following approval from the 
Institutional Review Board (IRB) at the University of Kentucky (UK). Sample sizes of 8 in each 
group achieve 80% power to detect a difference in VHI (pre and post intervention) of 14.3 in the 
voice therapy group and 0.5 change in vocal hygiene group.16 An n of 16, with 8 participants in 
each group was determined considering VHI change and a common standard deviation equal to 
11.6, a significance level (alpha) of 0.1, and a two-sided z-test.16 These results assume that 2 
sequential tests are made using the O'Brien-Fleming spending function to determine the test 
boundaries. Stage III was designed as Phase 2 clinical trial. Participants were randomly assigned 
to one of two groups: VFE+VH (Vocal Function Exercise + Vocal Hygiene) or VH (Vocal 
Hygiene).  
Participants 
 After completion of informed consent, 12 participants were recruited for the study. 
Participants in both groups met the following inclusion criteria; adults over 18 years of age, 
previously irradiated for laryngeal cancer (with or without chemotherapy), hearing levels 
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appropriate to follow directions, and deemed cancer-free by the treating physician at the time of 
study recruitment. Participants had to have completed XRT at least 6 months prior to study 
participation. Presence of vocal fold paralysis or surface vocal fold pathology at the time of study 
recruitment constituted exclusion from the study.  
Assessment battery 
Participants in both groups underwent the same multidimensional vocal assessment 
battery. The battery included assessment protocols belonging to the five domains of voice 
assessment and was the same assessment battery used for Stage II of the dissertation. A checklist 
for the assessment battery is available in Appendix I. The five common domains of voice 
assessment are: auditory-perceptual measures, patient self-assessment, acoustic analyses, 
aerodynamic analyses, and laryngeal imaging or visual-perceptual assessments. Outcome 
measures and their normative values are available in Table 4.1. Outcome measures are listed 
below with reference to each domain of voice assessment.  
5) Auditory- perceptual assessment: The Consensus Auditory-Perceptual Evaluation of Voice 
(CAPE-V- Appendix II) was utilized. Blinding: Audio samples of patients’ voices reading the 
rainbow passage (Appendix III) were presented to a licensed and certified speech-language 
pathologist with over 40 years of clinical experience in the field of voice disorders. The 
assessor was blinded to group assignments. 
6) Patient self-assessment: Voice Handicap Index (Appendix IV) was utilized. Total scores and 
domain specific scores (Physical, Functional, Emotional) were included for final analysis. 
7) Acoustic analyses: The Multidimensional Voice Profile (MDVP) and Analysis of Dysphonia 
in Speech and Voice (ADSV) were utilized. Specific measures included jitter, shimmer, noise 
to harmonics ratio (NHR), maximum phonation time (MPT) and pitch range for MDVP; and 
Cepstral Spectral Index of Dysphonia (CSID) was used for ADSV stimuli.197 CSID included 
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sustained vowel and sentence stimuli. Sentences included easy onset, voiceless plosive, all 
voiced and hard glottal attacks.  
8) Laryngeal imaging/visual perceptual assessment: Measures included were laryngeal 
stroboscopy and high-speed laryngeal imaging. Stroboscopic and high-speed features were 
rated on a scale (Appendix V). Stroboscopic and high-speed parameters include glottic 
closure, mucosal wave, amplitude of vibration and phase symmetry. Ratings were performed 
by a licensed and certified speech-language pathologist with over 40 years of clinical 
experience in the field of voice disorders. The speech-language pathologist was blinded to 
group assignment.  
Instrumentation 
1) Laryngeal stroboscopy: Laryngeal stroboscopy was performed using the Kay Elemetrics 
Rhino-Laryngeal Stroboscope – (Model RLS 9100 B, Halogen lamp: 150 watts, Xenon lamp: 120 
watts, frequency range: 60 Hz – 1000 Hz, laryngeal microphone), a Kay Elemetrics 70 degree 22 
rigid scope (Model 9106, total length: 252 mm), Kay distal endoscope, and a C-mount camera 
(Panasonic 3CCHD).  
2) High-speed digital imaging: For the HSDI recordings, a KayPentax high-speed system model 
9710 was used. Images were recorded at 4000 frames/s for a maximum duration of 4 seconds 
with a spatial resolution of 5123256 pixels. A 300W Xenon light source was used.  
3) Acoustic analysis: For acoustic assessment, the Computerized Speech Lab Model 4500 by 
KayPentax was used with a hand-held microphone (mouth-to-microphone distance = 3 inches) 
[System Requirements: Analog Inputs: 4 channels: two XLR and two phono-type, 5mV to 10.5V 
peak-to-peak, adjustable gain range >38dB, 24-bit A/D, Sampling Rates: 8,000-200,000Hz, 
THD+N: <-90dB F.S. Frequency Response (AC coupled): 20-22kHz +.05dB at 44.1kHz. Digital 
Interface: AES/EBU or S/P DIF format, transformer-coupled. Software Interface: ASIO and 
MME. Computer Interface: PCI (version 2.2-compliant), PCI card; 5.0" H x 7.4" W x 0.75" D 
(half-sized PCI card). Analog Output: 4 channels, line and speaker, headphone output, channels 1 
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& 2 provide line & speaker outputs. Physical: 4" W x 8.25" H x 12.5" D, 4 lbs. 12 oz., 45 watts, 
speaker, and microphone (Shure SM-48 or equivalent, XLR-type)]. 
4) Aerodynamic analysis: The Phonatory Aerodynamic System Model 6600 by KayPentax was 
used for the aerodynamic measurements (300 ml pneumotachograph - System requirements same 
as CSL model 4500). Airflow measures were taken using an airflow mask and a 
pneumotachograph, which uses the principle of differential pressure across a known resistance to 
estimate airflow rate. 
Study Interventions 
Participants were randomized to one of two intervention groups based on a pre-determined 
randomization protocol. Participants were randomized to the VH group or VFE + VH. Each 
intervention lasted for 6 weeks. The two intervention methods are described in detail below: 
I) Vocal hygiene counseling: Vocal hygiene counseling involved educating and informing 
patients regarding factors that influence voice use and voice care. Sessions generally 
revolved around strategies that enhance and maintain vocal health. These include tips on 
healthy voice use, hydration and dietary modifications required to maintain a healthy 
vocal system. Post-radiation vocal hygiene counseling stressed hydration and dietary 
considerations since significant changes in salivary status and tissues are noted during 
this period. 
II) Vocal Function Exercises: Vocal Function Exercises (VFEs) are a series of isometric and 
endurance-based exercises which aim at strengthening and balancing the three sub-systems 
of voice production, specifically respiration, phonation and resonance. VFEs also aim 
directly at strengthening vocal fold musculature thus improving their vibratory 
characteristics. The exercises program consists of a series of four exercises which include a 
warm-up, vocal fold stretching, vocal fold contraction and endurance exercise. The warm-
up and endurance exercises are timed (in seconds) and performed on strategically 
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determined musical notes. The VFE program for the proposed study lasted 6 weeks where 
the patient was required to perform the exercises twice a day, every day. As a result, these 
exercises relied heavily on compliance.  
Treatment plan: Specific treatment plans are described below in detail: 
Vocal hygiene group: During the pre-intervention assessment, each study participant attended a 
session on voice care with a licensed and certified speech-language pathologist trained 
specifically in the care of patients with laryngeal cancer. Participants were also provided with 
handouts with tips about vocal hygiene. Participants followed up 6 weeks later to undergo post-
intervention assessments. Participants in the VH group were seen a total of 2 times (pre-
intervention and post-intervention). Appendix VI contains details regarding the Vocal Hygiene 
Handout. 
VFE + VH group: During the pre-intervention assessment, each study participant attended a 
session on voice care with a licensed and certified speech-language pathologist trained 
specifically in the care of patients with laryngeal cancer. Participants were also provided with 
written handouts that included tips on vocal hygiene.  Participants were then taught Vocal 
Function Exercises (VFEs) by the same speech-language pathologist trained in the administration 
of VFEs (Please refer to Appendix VII for description and log sheets for VFEs). Participants were 
given an audio CD with the VFEs as well as log sheets to track their maximum phonation times 
during twice-daily exercise. Patients were monitored through weekly in-person or distance 
sessions to monitor both technique and progress. They underwent the above described 
assessments at the beginning of therapy and after 6 weeks of exercises. 
Statistical analysis 
Statistical analyses were performed using SPSS ver.22. Statistical analyses included 
descriptive statistics, frequencies and comparisons between VFE+VH and VH only groups. 
Comparisons for continuous variables between the two groups were performed using paired t-
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tests. Continuous variables included CAPE-V measures, VHI scores, acoustic measures (jitter, 
shimmer, Noise to Harmonic Ratio, Maximum Phonation Time, pitch range and CSID measures). 
Comparisons for non-continuous variables between the two groups were performed using the 
McNemar’s test. Non-continuous variables included stroboscopic and high-speed parameters. 
Significance levels were set at 0.1. 
Results 
  Following completion of informed consent, 12 participants were recruited for the study. 
However, one participant from each group had to be excluded from the study. The participant 
from the VFE+VH group opted out of the study citing personal reasons. The participant from the 
VH group had concerning findings for recurrent disease during her routine follow-up visit. She 
underwent biopsies which were negative for recurrent disease. Data from 10 participants were 
included for the final analysis. 
The mean age in the VH group (n=4) was 69 years (SD: 5.34) and the mean age in the 
VFE+VH group (n=6) was 57.5 years (SD: 14.2). All participants in the VH group had a history 
of early glottic cancer and had received narrow field radiation therapy as treatment. The VFE+VH 
group consisted of three participants with early glottic cancer and three participants with 
advanced stage glottic (n=1) and supraglottic cancer (n=2). Three participants with a history of 
early glottic cancers had received narrow field radiation therapy (XRT), while participants with a 
history of advanced laryngeal cancers had received wide field radiation therapy and adjuvant 
chemotherapy. Time since completion of XRT for the VH group ranged from 18 months to 48 
months. Time since completion of XRT in the VFE+VH group ranged from 24 months to 84 
months. The VH group consisted of two current smokers and two former smokers. Five 
participants in the VFE+VH group were non-smokers and one participant was a former smoker. 
The average pack years of smoking in the VH group was 70 pack years (SD: 43.97) and in the 
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VFE+VH group was 33.5 pack years (SD: 40.25). Patient demographics and characteristics are 
available in Table 5.1. 
As stated above, participants in each group underwent the entire assessment battery at 
pre-intervention and at 6 weeks. Participants in the VFE+VH group underwent in-person or face 
to face (distance: Skype/Facetime) therapy weekly. Participants in the VH group were seen only 
at the pre-intervention and post-intervention session. The numbers of sessions attended by 
participants of the VFE+VH group are presented in table 5.2. The table also informs the reader on 
the adherence to the entire VFE protocol. Traditionally, VFE activities are to be performed two 
times each, twice a day (2x2). However, only three participants performed the entire VFE 
protocol (2x2). Three participants performed the VFE protocol only two times each, once per day 
(2x1). Three participants attended voice therapy with the principal investigator (in person) at UK. 
Three participants received voice therapy over Skype or Facetime (distance) with the principal 
investigator. In addition, participants in the VFE+VH group also received VFE exercises on an 
audio CD. 
 The next sections will discuss results related to pair wise comparisons for continuous 
variables by group.  
Paired t-tests 
 Paired t-test results in the present section will be discussed according to the five domains 
of voice assessment. For ease of discussion, only statistically significant results are presented in 
this section. Means and standard deviations for all parameters under study for the two groups are 
available in tables 5.3 – 5.13. 
Patient self-assessment: Overall a decrease in VHI scores was seen across all domains in both 
groups; however pre and post VHI scores were significant for the physical domain (p=0.03) in the 
VFE+VH group (Table 5.3). Pre and post VHI measures were not statistically significant for any 
of the VHI scores in the VH group (Table 5.4). 
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Auditory-perceptual measures: An overall decrease in CAPE-V scores was observed across all 
CAPE-V parameters in both groups (Table 5.5,5.6). However, pre and post CAPE-V parameters 
were statistically significantly different for the CAPE-V overall severity score only in the 
VFE+VH group (Table 5.5). CAPE-V parameters in the VH group did not approach statistical 
significance. 
Acoustic analysis: An overall improvement in acoustic parameters was observed across both 
groups (Tables 5.7, 5.8). In the VFE+VH group, the average CSID for easy onset sentences 
(EOS) showed an increase in scores which indicates a worsening in this parameter. The VFE+VH 
group showed statistical significance for improvements in pitch range and maximum phonation 
time (Table 5.7). The VH group values did not approach statistical significance across any of the 
parameters (Table 5.8). 
Aerodynamic analysis: Overall trends for aerodynamic measures were highly varied for both 
groups under study. The VFE+VH group demonstrated a statistically significant pre-post 
difference for subglottic pressure (PSub) (Table 5.9). The VH group did not show statistical 
differences across any aerodynamic parameters (Table 5.10). 
Laryngeal imaging (Stroboscopic and high-speed parameters): Pre to post changes were seen 
for stroboscopic parameters of mucosal wave, amplitude and phase symmetry in the VFE+VH 
group (Tables 5.11). The VH group did not show any pre-post change on stroboscopic parameters 
(Table 5.12).  On high speed imaging, changes were observed pre-post for amplitude of vibration 
in the VFE+VH group (Table 5.13). The VH group did not show any pre-post changes on high 
speed parameters (Table 5.14). 
 A challenge that we faced through the present data analysis was the high variability seen 
in the data, which was compounded by our low sample size. To make our data more 
comprehensive, Table 5.15 provides an analysis of improvement by participant. If an 
improvement was seen in one or more parameters of one domain, the domain column was marked 
with an ‘+’. Table 5.15 provides the number of improved domains for each participant at post-
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intervention assessment. Overall, none of the participants in the VH group showed an 
improvement across all five domains. Three participants in the VFE+VH group showed 
improvements across select parameters in all five domains of voice assessment. However, for our 
primary outcome measure of VHI, improvements were made in both groups across all but one 
participant in each group.  
Discussion 
Previous studies have demonstrated improvements in voice-related quality of life and auditory-
perceptual measures of voice as a result of voice therapy interventions following radiation 
therapy for laryngeal cancers.13-16 The present study supported these previous findings since 
greater improvement was noted in the VHI physical domain and the CAPE-V measures for 
overall severity in the VFE+VH group as compared to the VH only group. Statistically significant 
differences were also seen in the VFE+VH group for parameters of pitch range (acoustic 
analysis), MPT (acoustic analysis) and Psub (aerodynamic analysis). The VH group did not show 
statistically significant changes across any of the parameters, further strengthening previous study 
findings that VH alone is not highly effective in improving voice quality and but rather is most 
useful when paired with a physiologic voice therapy approach.20 To account for the high 
variability of data seen in the present study, we also performed an analysis accounting for the 
improvement seen in each domain by each of the study participants. This analysis demonstrated 
that 50% of participants in the VFE+VH group showed improvement across all five domains of 
voice assessment, while 0% of participants in the VH group showed improvement across all five 
domains. However, for our primary study outcome, VHI, an improvement was seen across all but 
one participant in each group. Though none of the improvements in VHI in the control group 
were statistically significant, it is possible that participants were more aware of voice care 
strategies, and as a result, experienced an improved voice-related quality of life. The use of VH 
therefore cannot be discounted in the present study population. Not surprisingly, study 
71 
 
participants who completed the full VFE protocol improved across all domains of voice 
assessment. This supports previous study findings by Nguyen et.al.106 who demonstrated that 
individuals who completed the full VFE protocol showed the largest magnitude of improvement 
as compared to individuals who completed the partial VFE protocol. However, these results were 
demonstrated in individuals with no prior history of radiation therapy for HNC. Our findings 
showed pre to post intervention changes in the VFE+VH group for mucosal wave, amplitude and 
phase symmetry on stroboscopy. No changes were seen for laryngeal imaging studies 
(Stroboscopy and high speed) in the VH group. However, the judgement of laryngeal imaging 
parameters was challenging due to the generalized abnormality of laryngeal structures that occur 
as a result of XRT. Although certain stroboscopic and high speed parameters improved, the pre-
post results did not shift from abnormal to normal. This is in agreement with the objective voice 
parameters obtained at the post intervention period for both groups. Although an improvement 
was observed in objective parameters such as CAPE-V, acoustics and aerodynamics, not all 
participants approached normative clinical values. Clinically, these findings are significant since 
it is quite possible normal voice production or normative clinical values may not be a realistic 
goal in this population. Ideally, the clinical goal should be targeted towards improvement and 
overall functionality of voice production.  From our previous chapter, it is evident that high-speed 
laryngeal imaging was a better assessment tool for assessing vocal fold vibratory features, and we 
still advise clinicians to use it as an assessment tool for this population. Subglottic pressure 
measures appear to be affected the greatest in this population. All participants in the study 
demonstrated elevated Psub levels, which is reflective of the chronic edematous changes that 
occur in the irradiated larynx.9,12,14 Elevated Psub levels persisted even after completion of both 
interventions.                                                                                                                                    
In conclusion, VFEs in combination with vocal hygiene were found to be effective in improving 
vocal function across all five domains of voice assessment in 50% of our study participants. 
Vocal hygiene alone was not found to be effective in improving vocal function across all five 
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domains in any of the study participants. Even though these findings are difficult to generalize 
due to our limited sample size, these study findings serve as promising pilot data in demonstrating 
the utility of VFEs in individuals irradiated for laryngeal cancers. 
Limitations                                                                                                                                        
We were unsuccessful in accruing our required sample size as dictated by the power analysis. 
One of the greatest challenges for our study participants in both groups was travel distances with 
distances ranging from 80 miles (Somerset, KY) to a 115 miles (Hazard, KY). When given the 
option for voice therapy over Facetime or Skype, we experienced issues with insufficient 
computer literacy and lack of smartphone/computer accessibility. For future studies, the option of 
organized telehealth for a cost-effective method of delivery of voice therapy should be explored.  
The issue of availability for voice therapy can also be resolved by changing the time of 
recruitment. In the present study, participants were recruited 6 months after the completion of 
XRT. At this time, patients only make visits to their treating physician at a 6-month intervals. For 
future studies, patients may be recruited during  XRT intervention since they need to be present at 
the medical center every day for 6 weeks throughout the treatment. Another limitation of the 
study was the discrepancy in the degree of attention to treatment received by the participants in 
the VH only group versus the VFE+VH group. The VH group received only one in-person 
session on vocal hygiene counseling which is a typical clinical practice across most centers. 
Participants in the VFE+VH group were seen in person or via distance weekly and could address 
any questions that participants had pertaining to vocal hygiene. As a result, it is possible that 
participants in the VFE+VH group were more adherent to their vocal hygiene routine as well, 
secondary to increased contact with the treating professional (SLP). For future studies, the VH 
group ideally should receive weekly check-in sessions as well to monitor adherence. 
The next chapter provides the reader with a synthesized discussion on the three stages of 
the dissertation study. 
73 
 
CHAPTER 6: SYNTHESIZED DISCUSSION 
The principal focus of this dissertation was to investigate the efficacy of Vocal Function 
Exercises (VFEs) in adults irradiated for laryngeal cancers. This investigation was performed in 
three systematic stages that are listed below.  
Stage 1: This stage involved identifying patients who had been irradiated for laryngeal cancers at 
the University of Kentucky (UK). However, considering the rising incidence of head and neck 
cancers in Kentucky, we extended the study to all head and neck cancers (HNC). In addition to 
helping identify our study population, this study stage was helpful in highlighting the head and 
neck cancer burden in Kentucky, with a special focus on Appalachian Kentucky. 
Stage 2: Disorders of voice production as a result of radiation therapy are a well-documented 
clinical entity. However, few studies have performed a multidimensional analysis of voice 
production in the irradiated population. To paint a holistic picture of voice problems in the 
irradiated population, we performed a detailed voice assessment battery in adults irradiated for 
laryngeal cancers. This stage further helped highlight physiological and psychosocial issues as a 
result of disordered voice production in this population since multiple dimensions of voice 
production were affected as a result of radiation toxicity in our study population.  
Stage 3: Stage 3 focused on the rehabilitation of physiological and psychosocial issues identified 
in Stage 2 by implementing a systematic prescriptive evidence-based voice therapy program 
(Vocal Function Exercises) in adults irradiated for laryngeal cancers. Presently there is a dearth of 
evidence in the field of voice rehabilitation following radiation therapy (XRT) for laryngeal 
cancers. This stage was designed as a Phase 2 clinical trial to investigate  the efficacy of the VFE 
program in the current study population with the intent of collecting preliminary (pilot) data to 
justify a larger multicenter clinical trial. A VFE + vocal hygiene group was compared to vocal 
hygiene counseling in isolation, which has been the most commonly used intervention method for 
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voice rehabilitation in this population. Based on our preliminary data, VFEs appear to be a 
promising voice therapy method for exploration in the treatment of voice problems following 
radiation therapy (XRT) when compared to vocal hygiene alone (VH). 
 The following section summarizes and discusses findings from all three study stages. 
            Stage 1 of the dissertation study highlighted the head and neck cancer burden in 
Kentucky, with a focus on trends in Appalachian Kentucky.  A larger proportion of patients 
diagnosed and/or treated at UK belonged to Appalachian Kentucky as compared to urban 
Kentucky. Within urban and Appalachian Kentucky, a larger number of patients were diagnosed 
with advanced stage HNC during the specified study period (January 1, 2008 to December 31, 
2010). Advanced HNCs are often treated with multiple modalities which can be a combination of 
surgery and/or radiation therapy and/or chemotherapy. Each of these modalities by themselves is 
associated with treatment-related morbidity. Consequently, a combination of multiple modalities 
further intensifies treatment-related morbidity.  The need for multi-modality treatment also adds 
to the cost burden. High levels of treatment-related morbidity coupled with a significant cost 
burden can have negative effects on an individual’s overall quality of life and can hamper overall 
recovery after treatment. The cost burden is especially significant for patients in Appalachian 
Kentucky since 54 Appalachian counties of Kentucky have socioeconomic status factors which 
are the poorest among all Appalachian regions of the United States. 167,171,180 In addition, patients 
treated for advanced HNCs often require long-term voice and swallowing rehabilitation.45 The 
issue of requiring long-term voice and swallowing rehabilitation is further compounded by the 
limited access to medical facilities in these geographic regions 166,167,172,173  which can result in 
this population remaining largely underserved. To alleviate the issue of healthcare access and 
costs, outreach programs that focus on prevention through education, and early identification 
through screening for HNCs can be implemented. Early diagnosis and intervention of HNC 
reduces the need for multimodality treatment, improves treatment outcomes, and can 
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consequently reduce treatment costs. To this end, we plan to implement outreach programs with a 
focus on education, screening and prevention of HNCs in the identified high-risk counties in 
Appalachian Kentucky. While steps are yet to be taken to address issues related to late diagnosis 
in Kentucky, there is a large population of patients that have been treated for HNCs who require 
subsequent long-term voice and swallowing rehabilitation. As a result, voice and swallowing 
rehabilitation following treatment for HNCs is an issue that requires special attention in 
Kentucky.  For the present dissertation, our focus was on voice rehabilitation following XRT for 
laryngeal cancers. In the current sample the most commonly diagnosed HNC site was laryngeal 
cancer and a majority of these patients were treated with XRT. Therefore, we can expect to see a 
large proportion of patients with long-term voice problems as a result of post-radiation sequelae. 
The next section describes stage 2 of the study which was aimed at characterizing vocal function 
in adults previously irradiated for laryngeal cancers.  
 As established in previous chapters, voice production is negatively affected as a result of 
XRT. Stage 2 presented the reader with a holistic picture of physiological and psychosocial 
changes in voice production that occur as a result of XRT. This study stage also compared the RT 
(radiation therapy group) group’s voice production characteristics to a control group of 
individuals who were matched in terms of age, sex and pack years of smoking. Data from 18 
participants (RT=10, control=8) were included for final analysis. The RT group consisted of one 
patient that had a history of advanced laryngeal cancer and 9 patients with a history of early 
glottic cancer. The participant with advanced laryngeal cancer was the only participant who had 
received adjuvant chemotherapy as part of treatment. For the first time, the voice assessment 
battery consisted of a detailed assessment protocol which included all five domains of voice 
assessment. These domains encompass the physiological and psychosocial factors of voice 
production. The study demonstrated that voice production in the RT group was significantly more 
disordered across all five domains of voice assessment as compared to the control group. These 
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findings in the RT group also reiterated the long term deficits in vocal function as a result of XRT 
11,17,45 since the time of completion from treatment was 24-84 months. None of the participants in 
the RT group showed normal clinical values across all five domains of voice assessment. Our 
study findings were consistent with previous study findings which have investigated the effects of 
XRT on voice quality. These changes are not only seen in parameters of voice production, but 
also at the level of laryngeal tissues and intrinsic laryngeal muscles.31,129 Studies by Tedla et.al 
and Johns, et.al both demonstrated long term changes in intrinsic laryngeal muscles which were 
characterized by reorganization of muscle fibrils and increased deposition of collagen. 31,129 The 
study by Johns et.al. also showed an increase in fibronectin levels in the superficial layer of the 
lamina propria. All of these findings would translate into reduced pliability of the vocal fold 
tissues. 31 These changes were reflected in the stroboscopic and high speed laryngeal parameters 
in the present RT group since a larger proportion of participants demonstrated abnormal vocal 
fold vibratory characteristics as compared to the control group. In addition, 80% of participants in 
the RT group were judged as having abnormal vocal fold findings such as erythema, edema and 
increased vascularity. Disruption in voice production was also reflected in the patient self 
assessment, auditory perceptual, acoustic and aerodynamic measures. Participants in the RT 
group demonstrated a higher score on the VHI which reflects a greater voice handicap. The scores 
in the physical domain of the VHI  were affected the greatest. Individuals scored themselves high 
on items that were related to the voice sounding creaky, breathy, or dry. These changes perceived 
by participants were reflected in increased auditory-perceptual ratings of roughness, breathiness, 
and strain on the CAPE-V. These auditory-perceptual ratings were further reflected in the 
acoustic and aerodynamic findings in the RT group. Perturbation and noise measures were higher 
in the RT group, however these measures were not statistically significant. The aerodynamic 
measure that was significantly different between the two groups was Psub. The increase in PSub 
levels is indicative of the increased stiffness and decreased pliability observed in vocal fold 
tissues. These findings are consistent with laryngeal findings in the present study group since the 
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majority of participants in the RT group showed vocal fold edema and decreased pliability of the 
vocal folds (100% showed a reduced amplitude of vibration and 90% showed a reduced mucosal 
wave). The entire sample in the RT group also demonstrated laryngeal hyperfunction which is an 
indicator of faulty compensatory patterns resulting from sensory and motor feedback changes in 
the laryngeal mechanism. This stage of the study further strengthened previous study findings of 
long term, and in some cases permanent deleterious voice changes as a result of XRT. Despite the 
fact that these changes in voice production are well established, currently, there is no standardized 
treatment to the rehabilitation for voice problems in this population. 
The next stage, stage 3 of the study investigated the efficacy of a well-researched, 
prescriptive voice therapy approach in improving vocal function in adults irradiated for laryngeal 
cancers.  This stage of the study was aimed at investigating a standardized treatment protocol for 
this population. The following section summarizes results from stage 3 of the dissertation. 
 The focus of Stage 3 was on investigating the efficacy of Vocal Function Exercises 
(VFE) in improving vocal function in adults irradiated for laryngeal cancers. VFEs are a set of 
laryngeal manipulations which are aimed at strengthening and rebalancing the three subsystems 
of voice production.21 This exercise program is highly prescriptive and allows for easy plotting of 
progress through the course of voice therapy. To date, there are 23 peer-reviewed studies which 
have demonstrated the efficacy of VFEs in elite voice users, normal voices, pathological voice 
disorders and individuals over the age of 60 years. 18,19,22,35,36,69,87,88,91,101-114 However, the efficacy 
of VFEs utilized with patients irradiated for laryngeal cancers has never been studied. Previous 
studies that investigated voice rehabilitation subsequent to XRT have demonstrated an 
improvement in voice related quality of life and auditory-perceptual measures. However, none of 
these studies have specified their intervention methods. Central to treatment approaches across 
these studies has been vocal hygiene counseling. 13-16 To this end, the present study compared the 
efficacy of VFEs to vocal hygiene (VH) in improving vocal function in the current study 
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population. Participants were randomized to either the VFE+VH group or the VH group. The 
intervention period was 6 weeks. The primary end point for our study was improvement in VHI 
scores and secondary end-points included improvements in auditory-perceptual, acoustic, 
aerodynamic, stroboscopic and high speed measures. These parameters were selected based on 
the five domains of voice assessment. Study findings demonstrated an overall statistically 
significant improvement in patient self-assessment and select auditory perceptual measures. 
These results were consistent with previous study findings from Van Gogh, et.al,15,16 Tuomi 
et.al.,14 and Bergstorm, et.al.13 Select stroboscopic and high speed measures also improved in the 
VFE+VH group. Though select parameters in the VH group improved as well, none of the 
parameters were statistically significant at p=0.1.  
We also performed a detailed analysis by participant in each group. We analyzed the 
number of participants who improved across all five domains in both groups. Fifty percent of 
participants in the VFE+VH group demonstrated an improvement across all five domains. Zero 
percent of participants in the VH group showed improvement across all five domains. 
Interestingly, the three participants in the VFE+VH groups who showed the best adherence to the 
full VFE protocol showed an improvement in all five domains of voice assessment. This is 
consistent with previous study findings by Nguyen, et.al106  which demonstrated that participants 
who performed the full VFE protocol showed the greatest improvement in voice parameters when 
compared to those who completed a partial VFE protocol. However, the VH group also showed 
an improvement in some, if not all study parameters. Therefore the use of VH with the current 
population cannot be discounted. These improvements in the VFE+VH group support previous 
study findings which have demonstrated that VH is more effective when coupled with a more 
physiologic voice therapy approach such as VFE.18-20 These study findings support the utility of 
preliminary use of VFEs in this population. 
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Each of the above study stages had discrete study aims and hypotheses which are 
described below. In addition, the next section informs the reader on the acceptance or rejection of 
study hypotheses with respect to each dissertation stage. 
Specific aims and Hypotheses 
Stage 1 
Study title:  Addressing the head and neck cancer burden in Appalachian Kentucky: A single 
center experience 
Specific aim 1: To characterize the distribution of head and neck cancers in the treatment-seeking 
population at the University of Kentucky Markey Cancer Center in terms of site, stage, treatment 
trends, tobacco use and basic demographics in patients who sought treatment from January 2008 
to December 2010. 
Hypothesis: Specific aim 1 was purely observational and did not operate on a specific hypothesis 
Specific aim 2: To compare the distribution of head and neck cancers across Appalachian and 
non-Appalachian counties. Given the higher rate of tobacco use in Appalachian in comparison to 
non-Appalachian counties, we hypothesized that a larger number of patients identified at UK 
would belong to Appalachian counties. 
Hypothesis for specific aim 2 was accepted since a larger proportion of patients seen between 
2008 and 2010 belonged to Appalachian counties (n=278) as compared to non- Appalachian 
counties (n=198). 
Specific aim 3: To compare stage of cancer at the time of detection across Appalachian and non-
Appalachian counties. Considering the limited access to medical facilities faced by the 
80 
 
Appalachian population, 167 we hypothesized that the Appalachian population would have more 
advanced stage cancers at the their initial visit. 
Hypothesis for specific aim 3 was rejected because although a larger number of patients within 
Appalachian Kentucky were diagnosed with advanced stage HNC, proportionally non- 
Appalachian Kentucky showed a higher proportion of patients diagnosed with advanced stage 
HNC. 
Stage 2 
Study title: A study of vocal function using a multi-dimensional assessment battery in adults 
irradiated for laryngeal cancer 
Specific aim 1: To characterize vocal function in subjects who have been treated with radiation 
therapy for laryngeal cancers as determined by stroboscopic imaging, high-speed digital laryngeal 
imaging, acoustic, aerodynamic, and perceptual analyses and, patient self-report measures. 
Previous studies have reported deterioration of select parameters within all of the above domains 
of voice assessment after completion of radiation therapy. We hypothesized that the present study 
would follow similar trends.187,188 
Hypothesis for specific aim 1 was accepted since study participants in the RT group demonstrated 
clinically worse values on select parameters in all five domains of voice assessment as compared 
to the control group.  
Specific aim 2: To compare vocal function in individuals who have been treated with radiation 
therapy with age, sex and pack-years matched controls as determined by stroboscopic imaging, 
high-speed laryngeal imaging, acoustic, aerodynamic, perceptual and patient self-report 
measures.  Previous studies have reported deterioration in vocal function after radiation 
therapy.1,12,77,193,200 However, factors such as tobacco smoking and age-related changes have been 
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known to affect vocal function adversely as well.194,195 In an attempt to use matched controls, we 
matched subjects in the control group based on age, sex and tobacco use. We hypothesized that 
the present study would show clinically worse values of vocal function in the irradiated group as 
compared to the control group. 
Hypothesis for specific aim 2 was accepted because statistically significant differences were 
observed between select parameters of the five domains of domains of voice assessment between 
the RT and control groups with the RT group demonstrating worse clinical values of vocal 
function. 
Stage 3 
Study title: Investigating the efficacy of Vocal Function Exercises in improving vocal function in 
adults irradiated for laryngeal cancers 
Specific aim 1:  To investigate the efficacy of Vocal Function Exercises (VFE) for improving 
voice production in adults irradiated for larynx cancers as demonstrated by change in pre- and 
post-intervention Voice Handicap Index scores. The present stage was designed as a Phase 2 
clinical trial with Voice Handicap Index being the primary outcome measure. Secondary outcome 
measures include laryngeal stroboscopy, high-speed laryngeal imaging, acoustic analysis, 
aerodynamic analysis and auditory-perceptual measures. We hypothesized that the VFE + VH 
group will demonstrate significantly greater improvement in pre- and post-treatment Voice 
Handicap measures as compared to the VH only group.    
The hypothesis for specific aim 1 was accepted since a statistically significant change was seen in 
the VFE+VH group for the physical domain of the Voice Handicap Index for pre to post 
treatment measures at p<0.1. The VH group did not show statistically significant changes for any 
domains of VHI for pre to post treatment measures.  
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Specific aim 2: To investigate the efficacy of Vocal Function Exercises (VFE) for improving 
voice production in adults irradiated for larynx cancers as demonstrated by improvement in select 
parameters from the five domains of voice assessment. Outcome measures from the five domains 
of voice assessment include patient self assessment, auditory-perceptual measures, acoustic 
analysis, aerodynamic analysis, laryngeal stroboscopy, and high-speed laryngeal imaging. We 
hypothesized that the VFE + VH group would demonstrate a larger proportion of participants 
with an improvement across all five domains as compared to the VH only group.    
The hypothesis for specific aim 2 was accepted since 50% of participants in the VFE+VH group 
demonstrated an improvement across select parameters in five domains of voice assessment. 
None of the participants in the VH group showed an improvement across all five domains of 
voice assessment. 
CONCLUSIONS AND FUTURE DIRECTIONS 
 From the three stages of the present dissertation, we have established the need for 
standardized voice rehabilitation programs for patients following XRT. Stage 2 further 
strengthened previous study findings that demonstrated the deleterious effects of radiation 
therapy on overall vocal function. To this end, stage 3 provides us with preliminary data on the 
efficacy of a prescriptive and well-researched voice therapy program, known as Vocal Function 
Exercises (VFE) in the current study population. Our preliminary results are promising for the 
utility of VFEs in the irradiated population considering the improvement seen in our primary 
outcome measure as well as multiple voice parameters. Stage 1 was effective in highlighting the 
need for voice rehabilitation in our sample of the Kentucky population, especially Appalachian 
Kentucky owing to an observed high proportion of laryngeal cancers and high proportion of 
patients being treated with XRT. Stage 1 also highlighted the need for education, prevention and, 
screening programs for underserved areas of Appalachian Kentucky to reduce HNC-related 
morbidity and mortality, consequently improving survival and quality of life.  
83 
 
However, these studies were not without limitations which have been described in 
chapters 3,4, and 5. Future directions for each of these stages are directly related to study 
limitations as well as additional information that needs to be gained from this study population. 
Future directions with reference to each stage are described in the following section: 
Future directions for Stage 1: It is difficult to generalize the present study findings to the rest of 
Kentucky since we focused on a sample from a single center. For further analysis, data from the 
whole of Kentucky can be analyzed for the same study parameters. This would help us identify 
high risk regions that can be targeted for prevention and screening programs. One of the first 
steps to implementing such a program would ideally be collaborating with primary care 
physicians in the area. This is in keeping with the colorectal screening program in Kentucky, 
which as been so successful partially due to strong collaboration from PCPs in the community 
Future directions for Stage 2: Our study was limited in terms of sample size since we were 
unsuccessful in accruing the target sample size. In addition, the RT group was not equal in terms 
of site and stage since a majority of our participants had a history of early glottic cancers and only 
one participant was a history of advanced supraglottic cancer. For future studies, stratification of 
RT group by site and stage is suggested. Also, the majority of studies that have investigated vocal 
function following XRT have focused on early glottic cancers. It would be interesting to compare 
vocal function following irradiation of early and late stage laryngeal cancers. In addition, a 
baseline evaluation prior to XRT would be interesting to analyze as well to account for changes 
as a result of cancer itself and immediate treatment effects.  
Future directions for Stage 3: As previously stated, our study was limited in terms of sample size 
since we were unsuccessful in accruing the target sample size. This makes generalization of 
results to larger populations difficult. For future studies, accrual of a larger sample size is 
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suggested with a larger multicenter clinical trial. Similar to stage 2, participants need to be 
stratified by site and stage which would be possible with a larger sample size.  
Another drawback of this study was the discrepancy in the contact time with the treating 
SLP between each group. For future studies, an improved plan for assessing adherence to VH 
needs to be developed. In addition, the VH group should ideally receive the same contact time 
with the treating SLP as the VFE+VH group. The next step of this study needs to be extended to a 
larger population which should be followed up over a longer period of time. Fifty percent of the 
present study participants in the VFE+VH group demonstrated an improvement in all five 
domains of voice assessment, however whether these improvements can be maintained given the 
delayed nature of XRT is uncertain. Ideally participants need to be followed for up to 12 months 
to investigate whether these initial improvements in vocal function as a result of VFE+VH are 
maintained.  
The present study investigated the efficacy of VFE in adults who had completed XRT at 
least 6 months prior to study recruitment. Prophylactic swallowing exercises have been 
demonstrated to be efficacious in the alleviation of swallowing problems secondary to XRT.201,202 
Similarly, it would be interesting to investigate if implementation of VFE during XRT alleviates 
the severity of voice problems that occur after XRT.  
The effectiveness of exercise on the irradiated larynx also should also be assessed at the 
level of laryngeal tissues (intrinsic laryngeal muscles, vocal fold mucosa and laryngeal mucosa, 
laryngeal cartilage) to investigate if behavioral changes seen in voice parameters are in fact being 
engendered as changes at the structural level. This investigation can be accomplished by 
implementing an animal study where irradiated larynges are exposed to fictive exercise. 
Subsequently, these exercised tissues can be studied in detail to document structural or cellular 
improvements. 
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Summary 
These studies demonstrate that Kentuckians suffer with a disproportionately high 
incidence of head and neck cancers.  Radiation treatment for laryngeal cancer has significant and 
long-lasting physiological and psychosocial effects on voice production which significantly affect 
quality of life.  Vocal Function Exercises may provide a promising intervention approach for 
improving disordered voice production caused by the toxic effects of XRT.  These studies lay the 
groundwork for meaningful future studies aimed at prevention and treatment of this life altering 
disorder. 
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TABLES: CHAPTER 3 
Table 3.1: Site of primary lesion (n=476). Appalachian versus non- Appalachian 
distribution 
 
 
Table 3.2: Percentage of tobacco users (n=475, 1 missing), Appalachian versus non- 
Appalachian distribution  
Type of tobacco use Appalachian Non-Appalachian 
Cigarette smokers 190 129 
Never smokers/non- smokers 33 32 
Mixed use: Smoking+ smokeless tobacco 6 4 
Smokeless tobacco 6 3 
Cigar/ pipe  2 4 
Not recorded 40 26 
Total 277 198 
 
 
 
 
 
 
 
 
 
Site of lesion Appalachian Non-Appalachian 
Larynx 83 47 
Tongue 46 41 
Esophagus 37 30 
Oropharynx 2 1 
Gum and hard palate 21 19 
Floor of mouth 19 10 
Hypopharynx 15 9 
Buccal mucosa 2 2 
Nasopharynx 8 3 
Lip 6 2 
Salivary gland 10 7 
Tonsil 29 27 
Total 278 198 
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Table 3.3. Primary treatments administered (n=476), Appalachian versus non- Appalachian 
distribution  
Treatment modality Appalachian Non-Appalachian 
Chemotherapy (CT) + Radiation therapy (RT) 69 60 
Surgery  72 37 
Surgery + Chemotherapy+ Radiation therapy 62 46 
Surgery + Radiation therapy 34 24 
Radiation therapy 15 20 
No definitive treatment 20 9 
Chemotherapy 4 2 
Surgery + Chemotherapy 1 0 
Radiation therapy + Chemotherapy + other 
treatment 
1 0 
Total 278 198 
 
Table 3.4: Disease stage at the time of diagnosis (n=476), Appalachian versus non- 
Appalachian distribution  
Stage Appalachian  Non-Appalachian 
Stage 0 8 1 
Stage I 50 25 
Stage II 42 24 
Stage III 46 46 
Stage IV 114 89 
Unknown 18 13 
Total 278 198 
 
Table 3.5: Results from Fisher’s exact test comparing early versus late stage cancers 
between Appalachian and non- Appalachian regions 
Stage Counties Significance 2- sided (p<0.05) Appalachian  Non- Appalachian 
Early (Stage 0, I , II) 100 (38.4%) 50 (27%) 
0.014* Late (Stage III- IV) 160 (61.5%) 135 (72.9%) 
Total 260 185 
(*Fisher’s exact test p-value, indicates significance at p<0.05) 
 
Table 3.6: Results from Fisher’s exact test comparing single versus multimodality 
treatments in Appalachian and non- Appalachian regions 
Treatment Counties Significance 2- sided (p<0.05) Appalachian  Non- Appalachian 
Single modality 111 (39%) 68 (34%) 
0.249 Multi-modality 167 (60%) 130 (65%) 
Total 278 198 
(*Fisher’s exact test p-value) 
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TABLES: CHAPTER 4 
Table 4.1: Five domains of voice assessment with select assessment parameters 
Assessment 
Domain 
Test tool Measures Normative values 
Auditory 
perceptual 
Consensus Auditory 
Perceptual 
Evaluation – Voice 
(CAPE-V) 
Overall severity, roughness, 
breathiness rating (100 mm 
Visual Analog Scale) on the 
rainbow passage 
<10 for each parameter and 
overall severity 
Patient self- 
assessment 
Voice Handicap 
Index (VHI) 
Total score, physical domain, 
emotional domain and 
functional domain 
<10 on each domain 
<30 for total score 
Acoustic 
KayPentax® 
Computerized 
Speech Laboratory 
Jitter (%) 
Shimmer (dB) 
Noise-to-harmonics ratio 
(NHR)  
Pitch range 
Maximum phonation time 
(MPT) 
CSID /a/ 
CSID – easy onset 
sentence(EOS) 
CSID – all voiced sentence 
(AVS) 
CSID – hard glottal attack 
sentence (HGAS) 
CSID – voiceless plosive 
sentence 
Jitter <1% 
Shimmer <0.35dB 
NHR< 0.194 
Pitch range: variable 
MPT: variable (dependent on 
individual’s lung capacity)   
CSID /a/ -4.5 to 14 
CSID EOS -10.85 to 21.08 
CSID AVS -12.4 to 14.4 
CSID HGAS -8 to 19.6 
CSID VPS -0.6 to 29.2 
Aerodynamic 
KayPentax® 
Phonatory 
Aerodynamics 
System 
Mean airflow rate (L/s) 
Subglottal pressure (Psub) (cm 
H2O) 
Laryngeal airway resistance 
(LAR) (cm H2O/L/s) 
Phonation threshold pressure 
(PTP) (cm H2O) 
Airflow rate : 0.08 to 0.2  
Psub : 5-8 cmH20 
LAR : 30 to 60 
PTP: 3-5 
Visual 
imaging 
Laryngeal 
stroboscopy and 
high speed laryngeal 
imaging 
Glottic closure (GC), mucosal 
wave (MW), amplitude of 
vibration (AMP), phase 
symmetry (PS), overall 
appearance and appearance of 
vocal folds  
GC: 0- complete, 1-
insufficiency noted, 2- 
incomplete 
MW and AMP: 0- normal, 1-
reduced, 2-absent 
PS: 0 – symmetric, 1- 
asymmetric 
Overall appearance: 0-normal, 
1-abnormal and qualitative 
description 
Appearance of vocal folds: 
Qualitative description 
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Table 4.2: Participant demographics (n=18) for study 2 
  
Characteristics Number of participants Fisher’s 
exact  Radiation therapy (RT), n=10 Control, n=8 
Sex     
Male  7 6 0.618 
Female  3 2 
      
Age     
Mean (age in years)  66.1 55.5  
Standard deviation  12.96 13.8 
      
Stage (TNM stage)     
T1N0M0  8 N/A N/A 
T2N0M0  1 N/A 
T2N2  1 N/A 
      
Smoking status     
Never  2 1 0.618 
Former  6 3 
Current  2 4 
      
Pack years (mean and SD)  37.92 (38.9) 41.38 (23.62)  
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Table 4.3: CAPE-V findings (means and standard deviations by group) 
Parameter 
Group  Mean 
Std. 
Deviation 
CAPE- V overall 
severity 
Control 8 11.25 12.748 
RT 10 29.40 13.745 
CAPE- V pitch  Control 8 1.25 3.536 
RT 10 3.00 4.830 
CAPE- V loudness Control 8 7.50 11.339 
RT 10 29.90 19.186 
CAPE- V breathiness Control 8 5.63 9.039 
RT 10 32.00 12.419 
CAPE-V roughness Control 8 11.25 12.748 
RT 10 31.70 15.485 
CAPE- V strain Control 8 11.88 14.377 
RT 10 36.10 12.714 
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Table 4.4: CAPE- V comparisons – Parametric tests (Independent sample t-tests) 
Parameter t df Significance  
CAPE-V overall severity -2.873 16 .011* 
CAPE-V breathiness -5.024 16 .000* 
CAPE- V roughness -3.004 16 .008* 
(* indicates significance at p=0.05) 
 
Table 4.5: CAPE – V comparisons – non parametric tests (Mann-Whitney U test) 
Parameter Group 
(n=18) 
Median Range Std. error of 
mean 
p-value 
CAPE-V pitch Control (n=8) 0 0-10 1.25 0.388 
RT (n=10) 0 0-10 1.528 
CAPE-V 
loudness 
Control (n=8) 0 0-25 4.01 0.012* 
RT (n=10) 35 0-57 6.067 
CAPE- V 
strain 
Control (n=8) 5 0-35 5.08 0.007* 
RT (n=10) 35 20-57 4.021 
(* indicates significance at p=0.05) 
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Table 4.6: Voice Handicap Index (VHI) (means and standard deviations by group) 
Parameter Group n Mean Std. Deviation 
VHI total score Control 8 11.63 12.682 
Radiation 10 22.60 13.501 
VHI -Physical Control 8 4.88 4.673 
Radiation 10 13.30 9.476 
VHI-Functional Control 8 4.38 5.290 
Radiation 10 6.60 4.926 
VHI-Emotional Control 8 2.38 3.777 
Radiation 10 2.60 3.596 
 
Table 4.7: VHI comparisons – Parametric tests (Independent sample t-tests) 
Parameter t df Significance 
VHI total -1.760 16 0.098 
VHI -Physical -2.292 16 0.036* 
(* indicates significance at p=0.05) 
Table 4.8: VHI comparisons – non-parametric tests (Mann-Whitney U tests) 
Parameter Group Median Range Std.error of 
mean 
p- value 
VHI- 
Functional 
Control (n=8) 3 0-13 1.87 0.302 
RT (n=10) 6.5 0-16 1.56 
VHI- 
Emotional 
Control 1 0-11 1.33 0.812 
RT 1 0-11 1.13 
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Table 4.9: Acoustic analyses (means and standard deviations by group) 
Parameter Group n Mean Std. Deviation 
Jitter Control 8 1.095 .99 
RT 10 2.141 2.61 
Shimmer Control 8 0.353 .20 
RT 10 0.683 .87 
NHR Control 8 0.159 .051 
RT 10 0.209 .21 
MPT Control 8 18.82 4.40 
RT 10 15.03 8.9 
Pitch range Control 8 378.21 150.6 
RT 10 225.54 128.7 
CSID /a/ Control 8 12.84 10.92 
RT 10 23.79 21.72 
CSID EOS Control 8 11 14.93 
RT 10 18.62 19.13 
CSID AVS Control 8 2.97 10.88 
RT 10 8.62 20.39 
CSID VPS Control 8 16.47 10.99 
RT 10 19.4358 14.10456 
CSID HGAS Control 8 8.8349 8.76605 
RT 10 19.5928 29.28840 
 
 
94 
 
Table 4.10: Acoustic analysis – Parametric tests (Independent sample t-tests) 
Parameter t df Significance 
Shimmer -.912 15 .376 
Pitch range 2.118 13 .045* 
CSID a -1.286 15 .218 
CSID EOS -.906 15 .379 
CSID AVS -.697 15 .496 
CSID VPS -.478 15 .639 
CSID HGAS -.997 15 .335 
(* indicates significance at p=0.05) 
Table 4.11: Acoustic analysis – Non-parametric tests (Mann-Whitney U test) 
Parameter Group 
(n=18) 
Median Range Std. error of 
mean 
p-value 
Jitter Control (n=8) 0.678 0.376-2.82 0.351 0.248 
RT (n=10) 1.342 0.52-8.76 0.781 
NHR Control (n=8) 0.146 0.104-0.275 0.0183 0.563 
RT (n=10) 0.134 0.121-0.77 0.064 
MPT Control (n=8) 17.29 14-8-28.7 1.55 0.286 
RT (n=10) 13.94 1.86-29.54 2.74 
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Table 4.12: Aerodynamic analysis (means and standard deviations by group) 
Parameter Group n Mean Standard 
deviation 
Psub Control 8 6.03 1.73 
RT 10 9.08 2.41 
Mean airflow rate Control 8 0.205 0.29 
RT 10 .196 0.12 
LAR Control 8 60.04 31.74 
RT 10 74.69 84.71 
PTP Control 8 3.56 1.59 
RT 10 5.93 3.25 
 
Table 4.13: Aerodynamic analysis – Parametric tests (Independent sample t-tests) 
Parameter t df Significance 
Psub -2.952 15 .010* 
LAR -.460 15 .652 
PTP -1.844 14 .086 
(* indicates significance at p=0.05) 
Table 4.14: Aerodynamic analysis – Non-parametric tests (Mann Whitney U test) 
Parameter Group Median Range Std. error 
of mean 
p-value 
Airflow rate Control (n=8) 0.115 0.04-0.17 0.015 0.214 
RT (n=10) 0.215 0.02-0.43 0.036 
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Table 4.15: Stroboscopic parameters (percentage of patients with abnormal stroboscopic 
findings) 
Parameter Control (n=8) RT (n=10) 
Glottic closure 2 (25%) 4 (40%) 
Mucosal wave 4 (50%) 9 (90%) 
Amplitude  3 (37.5%) 10 (100%) 
Hyperfunction 8 (100%) 10 (100%) 
Overall appearance 3 (37.5%) 7 (70%) 
Phase symmetry 2 (25%) 7 (70%) 
VF appearance 3 (37.5%)  8 (80%) 
 
Table 4.16: Stroboscopic parameters (Fisher’s exact test) 
Parameter Significance 
Glottic closure 0.437 
Mucosal wave 0.239 
Amplitude * 0.009* 
Hyperfunction 0.236 
Phase symmetry 0.07 
Overall appearance 0.268 
(* indicates significance at p=0.05) 
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Table 4.17: High speed (percentage of patients with abnormal high speed findings) 
Parameter Control (n=7) 
Missing 1 
RT (n=8) 
Missing 2 
Glottic closure 2 (28.5%) 6 (75%) 
Mucosal wave 3 (42.8%) 6 (75%) 
Amplitude  2 (28.5%)  1 (12.5%) 
Phase symmetry 3 (42.5%) 3 (30%) 
 
Table 4.18: High speed laryngeal imaging parameters (Fisher’s exact test) 
 
Parameter Significance 
Glottic closure 0.073 
Mucosal wave 0.348 
Amplitude  0.194 
Phase symmetry 0.622 
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                                                        TABLES: CHAPTER 5                                                                                                          
Table 5.1: Participant demographics by group for study 3 (n=10) 
 
Table 5.2: Participant attendance and adherence to the VFE protocol 
Participant  Session type Percentage of 
sessions 
attended  
Performed full VFE 
protocol twice a day 
(2x2) 
Performed full VFE 
protocol once a day (2x1) 
1 In person 100% (6/6) X  
2 In person 100% (6/6) X  
3 Distance 66.6% (4/6)  X 
4 Distance 50% (3/6)  X 
5 Distance 66.6% (4/6)  X 
6 In person 66.6% (4/6) X  
 
 
 
Characteristics Number of participants Fisher’s exact 
 VH=4 VFE+VH, n=6 
Sex     
Male  4 3 0.164 Female  0 3 
      
Age    
Mean (age in years)  69 57.5 0.199 Standard deviation 5.34 14.2 
      
Stage (TNM stage)    
T1N0M0  3 3 
0.167 T2N0M0  1 0 T2N2 0 2 
 T3N0M0  0 1 
    
Treatment type   
Narrow field XRT 4 3 
0.167 Wide field XRT 0 3 
Chemotherapy+XRT 0 3 
    
Smoking status    
Never  0 5 
0.335 Current  2 0 
Former  2 1 
      
Mean pack years (SD)  70 (43.97) 33.5 (40.25) 0.11 
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Table 5.3: Voice Handicap Index (VHI) Paired t-test: VFE+VH group 
Parameter Mean  Standard 
deviation 
t df Significance 
Pre VHI total 39.50 19.807 1.38 5 0.224 
Post VHI total 32.50 23.020 
Pre VHI Physical 19.83 6.401 2.97 5 0.031* 
Post VHI Physical 15.67 8.524 
Pre VHI Functional 12.00 6.356 0.32 5 0.761 
Post VHI Functional 11.33 10.172 
(*Indicates significance at p= 0.1) 
Table 5.4: Voice Handicap Index (VHI) Paired t-test: VH group 
Parameter Mean  Standard 
deviation 
t df Significance 
Pre VHI total 26.00 18.779 .577 3 0.604 
Post VHI total 19.75 16.879 
Pre VHI  Physical 15.25 10.308 1.268 3 0.294 
Post VHI Physical 11.00 8.287 
Pre VHI Functional 7.00 8.083 .241 3 0.825 
Post VHI Functional 5.75 4.349 
 
Table 5.5: Voice Handicap Index (VHI) Wilcoxon sign test: VFE+VH group 
Parameter Group (n=6) Median Range Std. error 
of mean 
p-value 
VHI-Emotional Pre 2.5 0-31 4.84 0.892 
Post 4 0-14 2.419 
 
Table 5.6: Voice Handicap Index (VHI) Wilcoxon sign test: VH group 
Parameter Group (n=4) Median Range Std. error 
of mean 
p-value 
VHI-Emotional Pre 2.5 0-9 2.179 0.655 
Post 0.5 0-11 2.67 
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Table 5.7: Auditory-perceptual measures (CAPE-V scores) for VFE+VH group (Paired t-
tests) 
Parameter Mean  Standard 
deviation 
t df Significance 
Pre CAPE-V overall severity 34.83 30.499 2.025 5 0.099* 
Post CAPE-V overall severity 25.50 26.898 
Pre CAPE-V breathiness 10.17 11.462 1.663 5 0.157 
Post CAPE-V breathiness 7.00 9.879 
Pre CAPE-V roughness 32.50 28.933 1.963 5 0.107 
Post CAPE-V roughness 18.33 21.248 
(*Indicates significance at p= 0.1) 
Table 5.8: Auditory-perceptual measures (CAPE-V scores) for VFE+VH group (Wilcoxon 
sign tests 
Parameter Group (n=6) Median Range Std. error of 
mean 
p-value 
CAPE-V pitch Pre 6.5 2-25 4.088 0.715 
Post 7.5 0-25 3.069 
CAPE-V 
loudness 
Pre 1 0-10 1.585 0.317 
Post 0 0-10 1.633 
CAPE- V 
strain 
Pre 40.85 2-45 8.68 0.116 
Post 8.5 0-42 6.87 
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Table 5.9: Auditory-perceptual measures (CAPE-V scores) for VH group (Paired t-tests) 
Parameter Mean  Standard 
deviation 
t df Significance 
Pre CAPE-V overall severity 40.75 34.277 1.414 3 0.252 
Post CAPE-V overall severity 25.75 14.431 
Pre CAPE-V pitch  18.00 22.405 .994 3 0.393 
Post CAPE-V pitch  14.25 15.435 
Pre CAPE-V roughness 46.25 33.049 1.733 3 0.181 
Post CAPE-V roughness 20.00 19.131 
Pre CAPE-V strain 33.75 27.789 2.089 3 0.128 
Post CAPE-V strain 20.25 16.899 
(*Indicates significance at p=0.1) 
Table 5.10: Auditory-perceptual measures (CAPE-V scores) for VH group (Wilcoxon sign 
tests) 
Parameter Group 
(n=4) 
Median Range Std.error of 
mean 
p- value 
CAPE-V 
loudness 
Pre 2 2-10 2 0.655 
Post 2.5 0-10 2.17 
CAPE-V 
breathiness 
Pre 4 2-50 11.68 0.655 
Post 10 3-35 7.32 
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Table 5.11: Acoustic measures for VFE+VH group (Paired t-tests) 
Parameter Mean  Standard 
deviation 
t df Significance 
Pre jitter 2.55 1.43 .506 5 0.634 
Post jitter 2.24 1.58 
Pre MPT 15.03 5.76 -3.269 5 0.022* 
Post MPT 20.15 8.70 
Pre pitch range 290.05 260.79 -4.370 4 0.012* 
Post pitch range 565.47 126.21 
Pre CSID /a/ 36.921 27.47 .728 4 0.507 
Post CSID /a/ 30.237 28.635 
Pre CSID EOS 25.66 25.56 -.813 5 0.453 
Post CSID EOS 30.07 18.59 
Pre CSID AVS 20 30.83 .979 5 0.373 
Post CSID AVS 16.07 27.73 
Pre CSID VPS 30.86 27.17 1.17 5 0.295 
Post CSID VPS 24.71 17.58 
Pre CSID HGAS 31.81 36.69 1.270 5 0.260 
Post CSID HGAS 27.51 29.96 
(*Indicates significance at p=0.1) 
Table 5.12: Acoustic measures for VFE+VH (Wilcoxon sign tests) 
Parameter Group 
(n=6) 
Median Range Std.error of 
mean 
p- value 
Shimmer Pre 0.55 0.322-1.21 0.133 0.463 
Post 0.384 0.181-1.23 0.191 
NHR Pre 0.139 0.108-0.401 0.447 0.6 
Post 0.14 0.113-0.276 0.307 
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Table 5.13: Acoustic measures for VH group (Paired t-tests) 
Parameter Mean  Standard 
deviation 
t df Significance 
Pre jitter 3.77 3.61 .875 3 0.446 
Post jitter 1.95 .93 
Pre shimmer 1.56 1.41 1.333 3 0.275 
Post shimmer 0.67 0.43 
Pre NHR 0.38 0.31 1.288 3 0.288 
Post NHR 0.17 0.050 
Pre MPT 10.08 9.38 -1.328 3 0.276 
Post MPT 16.04 2.56 
Pre pitch range 222.15 197.56 -1.697 3 0.188 
Post pitch range 283.9 263.96 
Pre CSID EOS 28.32 7.03 1.581 3 0.212 
Post CSID EOS 19.11 10.28 
Pre CSID AVS 24.85 25.42 1.129 3 0.341 
Post CSID AVS 11.68 8.62 
Pre CSID VPS 23.67 7.33 1.479 3 0.236 
Post CSID VPS 8.67 17.18 
Pre CSID HGAS 34.58 22.46 1.340 3 0.273 
Post CSID HGAS 8.67 17.18 
 
Table 5.14: Acoustic measures for VH group (Wilcoxon sign tests) 
Parameter Group (n=4) Median Range Std. error 
of mean 
p-value 
CSID-AVS Pre 21.73 -0.833-56.79 12.71 0.465 
Post 15.17 -1.14-17.53 4.31 
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Table 5.15: Aerodynamic measures for VFE+VH group (Paired t-tests) 
Parameter Mean  Standard 
deviation 
t df Significance 
Pre Psub 11.59 3.66 -2.112 5 .088* 
Post Psub 14.07 1.63 
Pre phonation threshold 
pressure 
8.18 2.67 .891 5 .414 
Post phonation 
threshold pressure 
6.71 2.22 
(*Indicates significance at p=0.1) 
Table 5.16: Aerodynamic measures for VFE+VH group (Wilcoxon sign tests) 
Parameter Group 
(n=6) 
Median Range Std.error of 
mean 
p- value 
Airflow rate Pre 0.26 0.14-0.43 0.038 1.00 
Post 0.325 0.08-0.39 0.055 
Laryngeal 
airway 
resistance 
Pre 40.27 28.71-61.86 5.103 0.463 
Post 41.18 33.09-196.59 26.15 
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Table 5.17: Aerodynamic measures for VH group (Paired t-tests) 
Parameter Mean  Standard 
deviation 
t df Significance 
Pre Psub 8.22 2.79 0.456 3 0.679 
Post Psub 7.66 3.21 
Pre airflow rate 0.18 .054 0.805 3 0.480 
Post airflow rate 0.16 .038 
Pre Laryngeal airway 
resistance 
43.18 11.43 -0.081 3 0.941 
Post Laryngeal airway 
resistance 
44.19 21.009 
Pre phonation threshold 
pressure 
6.27 1.49 -0.486 2 0.675 
Post phonation 
threshold pressure 
7.63 5.48 
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Table 5.18: Pre to post differences for stroboscopic parameters for VFE+VH group 
Parameter (n= 4, Missing = 2) Significance 
Glottic closure 0.136 
Mucosal wave 0.062* 
Amplitude  0.017* 
Phase symmetry 0.05* 
Hyperfunction 0.329 
(Significant at p=0.1) 
Table 5.19: Pre to post differences for stroboscopic parameters for VH group 
Parameter (n=3, Missing=1) Significance 
Glottic closure 1.00 
Mucosal wave 0.513 
Amplitude  0.135 
Phase symmetry 1.00 
Hyperfunction 0.33 
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Table 5.20: Pre to post differences for high speed parameters for VFE+VH group 
Parameter (n= 4, Missing = 2) Significance 
Glottic closure 0.157 
Mucosal wave 0.238 
Amplitude  0.062* 
Phase symmetry 0.174 
(Significant at p=0.1) 
Table 5.21: Pre to post differences for high speed parameters for VH group 
Parameter (n= 2, Missing = 2) Significance 
Glottic closure 0.5 
Mucosal wave 0.33 
Amplitude  CNA 
Phase symmetry CNA 
(CNA=could not assess due to low sample size) 
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Table 5.22: Improvement in domain demonstrated by each study participant 
Participant by 
group 
(improved 
domains/total 
domains) 
Patient 
self 
assessme
nt 
Auditory 
perceptua
l 
Acoust
ic 
analysi
s 
Aerodynam
ic analysis 
Stroboscopic 
assessment 
High-
speed 
assessmen
t 
VH 1 (4/5)  + + + +  
VH 2 (3/5) + + +    
VH 3 (1/5) +     CNA 
VH 4 (3/5) + + +   CNA 
VFE+VH 1 
(5/5) 
+ + + + + + 
VFE+ VH 2 
(5/5) 
+ + + + + + 
VFE+VH 3 
(2/5) 
+  +    
VFE+VH 4 
(3/5) 
+ + +    
VFE+VH 5 
(3/4) 
 + + + CNA CNA 
VFE+VH 6 
(5/5) 
+ + + + + CNA 
(+ = improvement, CNA=could not assess) 
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                                     APPENDIX I: STUDY CHECKLIST    
 
Please circle ‘yes; for each item that has been completed                                                                                               
 
Subject #:  
 
 
Informed consent:   Yes / No 
 
VHI:  Yes / No: Score: Physical:  _____ , Functional: _____, Emotional: _____ , Total: _____ 
 
CAPE-V:    Yes / No 
Overall quality  
Pitch   
Loudness   
Breathiness  
 
Acoustics: Yes/No 
Fo  
Jitter   
Shimmer  
NHR  
Maximum Phonation Time  
CSID for /a/  
CSID for easy onset sentences  
CSID for voiced plosive sentences  
CSID for hard glottal attack 
sentences 
 
CSID for All voiced sentences  
 
Aerodynamics: Yes/No 
Vital capacity  
Mean airflow during voicing   
Mean peak air pressure  
Airway resistance  
Phonation threshold pressure  
 
 
Strobe: Yes/No, Exam: Flexible/Rigid 
0= normal / 1= Abnormal 
 
High Speed Laryngeal imaging : Yes/No, if ‘no’ please state reason:_____________________ 
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APPENDIX II: CAPE-V 
 
From: ASHA. Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) 
ASHA Special Interest Division 3, Voice and Voice Disorders. 2009  
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APPENDIX III: RAINBOW PASSAGE 
 
The rainbow is a division of white light into many beautiful colors. These take the shape of a long 
round arch with it its path high above and its two ends apparently beyond the horizon. 
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APPENDIX IV: VOICE HANDICAP INDEX (VHI) 
 
 
From: The voice handicap index (VHI) development and validation. American Journal of Speech 
Language Pathology. 1997;6(3):66-70. 
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APPENDIX V: STROBE AND HIGH SPEED RATING FORMS 
i) Strobe rating form: Blinded subject ID_____________________ 
Rater: _______________________ 
Glottic closure:  __________________ (0= complete, 1= insufficient – please identify type of 
insufficiency, 2= spindle shaped or incomplete) 
Phase symmetry: ___________________ (0= symmetric, 1= asymmetric) 
 
ii) HSV rating form: Blinded subject ID_____________________ 
Rater: _______________________ 
Glottic closure:  __________________ (0= complete, 1= insufficient – please identify type of 
insufficiency, 2= spindle shaped or incomplete) 
Phase symmetry: ___________________ (0= symmetric, 1= asymmetric) 
 
 
 
Parameter Right VF 
(0=normal, 1= reduced, 2= 
absent, 3= exaggerated) 
Left vocal fold 
(0=normal, 1= reduced, 2= 
absent, 3= exaggerated) 
Mucosal wave   
Amplitude   
Qualitative descriptors of 
TVFs (erythema, edema 
etc) 
  
Hyperfunction (0=no 
hyperfunction, 
1=hyperfunction present) 
 
Overall laryngeal 
appearance (0=normal, 
1=abnormal), description 
 
 
 
 
Parameter Right VF 
(0=normal, 1= reduced, 2= 
absent, 3= exaggerated) 
Left vocal fold 
(0=normal, 1= reduced, 2= 
absent, 3= exaggerated) 
Mucosal wave   
Amplitude   
114 
 
 
APPENDIX VI: VOCAL HYGIENE INFORMATION SHEET 
 
Voice Conservation & Vocal Hygiene: Tips for a Healthy Voice 
Side effects of Radiation therapy: Radiation therapy is an extremely effective and curative 
method used in the management of throat cancers. However you may have noticed a number of 
side effects through treatment. Many of these side effects occur due to the damage caused to the 
salivary glands during the course of radiation. These include: 
1) Dryness of the throat and mouth 
2) Difficulty swallowing 
3) Hoarseness 
4) Weight loss and nausea 
What is vocal hygiene? The following suggestions are meant to guide you in taking care of your 
voice and overcoming and preventing some voice problems. Vocal hygiene is positive change – 
suggestions that will make you feel better and make you sound better too! 
Drink lots of water: As mentioned one the main issues with radiation therapy is throat and 
mouth dryness due to damage to the salivary glands. One of the first steps to minimize dryness 
therefore is adequate hydration. The entire voice producing mechanism (mouth, throat, vocal 
folds and lungs, too) needs moisture to work efficiently. If you do a lot of talking (on the 
telephone, group meetings, one-on-one discussion) or singing, always have water nearby and take 
frequent sips. Sometimes, when people are not in the habit of drinking water, they don’t even 
realize that they are thirsty until after they begin drinking. And water is good for the health of 
your entire body. 
Limit Caffeine and Alcohol use: Both Caffeine and alcohol have significant drying effects on 
tissues of the mouth and throat. A way to stay well hydrated is to limit use of products that 
dehydrate vocal fold and oral structures. 
Don’t smoke and completely eliminate tobacco use: Smoking cigarettes, pipes, cigars and other 
substances can seriously harm your overall health, and damage the entire respiratory system 
including the upper airway, throat, mouth and nose. The heat and inhaled chemicals cause 
inflammation, swelling, sometimes irreversible damage, and cancer. The only way to counter the 
effects of smoking is to stop. 
Eliminate habitual and frequent throat clearing. We all must clear our throats on occasion, but 
recognize that when you clear your throat you are “slamming” the vocal folds together hard. This 
can damage the vocal folds by causing inflammation and localized irritation. It is common for 
people to get into the habit of clearing the throat after radiation therapy due to the dryness they 
experience.  
Control and limit vocal loudness. Do not speak louder than the situation or environment 
demands. Don’t “compete vocally”. Avoid yelling, loud cheering, speaking over loud noises. Use 
non-vocal methods to get the attention of others (i.e., clap your hands, raise your arm, blow a 
whistle, ring a bell, turn lights on and off). Use amplification in large or noisy places. Don’t try to 
“out talk” others by increasing loudness. Be aware of how you use your voice in talking over 
music, over the TV, communicating up and down stairs in the home, calling the dog, etc. 
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Balance extra vocal demands with voice rest. If you have to give a lecture or you know that 
you will be speaking for extended periods of time, try to reduce voice use before and after these 
episodes. If you must talk a lot at work, try to reduce the amount of talking outside of work. 
Listen more and talk less. If you know that you will be using your voice heavily in the evening 
(giving a lecture, talking in a noisy environment), then rest your voice more during the day and 
after the evening is over.’ 
Use caution with medications (over-the-counter and prescription). 
Decongestants, allergy medicines and some other drugs tend to release fluid from body tissues, 
including the vocal folds. If your doctor has recommended that you take these medicines, you 
need to try to counteract their drying effect by increasing your water intake. Ask you doctor if 
there are any alternative medicines that don’t have such a drying effect. Certain medications are 
also contraindicated after radiation therapy. Please consult your cancer care team before 
administering any new medication. 
(Adapted from The Voice and Swallowing Institute, New York Eye and Ear infirmary)  
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APPENDIX VII: VOCAL FUNCTION EXERCISE LOG SHEET 
 
Vocal Function Exercise Practice Record 
 
From: Stemple J, Glaze L, Klaben B. Clinical Voice Pathology: Theory and Management. 4th ed. 
San Diego: Plural Publishing; 2009. 
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